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Abstract 
The aim of this thesis was to investigate some of the potential health benefits of aronia berries 
with main focus on the phenolic substances. Extractions and fractionations of aronia berries 
were performed to obtain several crude extracts and subfractions. In addition, well known 
constituents of aronia berries (anthocyanins, procyanidins and phenolic acids) were isolated. 
The different samples obtained were then tested in various in vitro bioassays to determine 
their biological activities as antioxidants, α-glucosidase inhibitors, CYP3A4 inhibitors, and 
antibacterial agents.  
Pure anthocyanins and anthocyanin-rich extracts were found to be potent α-glucosidase 
inhibitors compared to the positive control acarbose, the active principle in an anti-diabetic 
drug. α-Glucosidase plays a vital role in digestion of carbohydrates and by inhibition of this 
enzyme, it might be possible to control postprandial hyperglycemia which is important for 
diabetic patients. Antioxidant activity was assessed by DPPH radical scavenging and by 
inhibition of 15-lipoxygenase and xanthine oxidase. In general, the substances tested 
displayed strong radical scavenging and 15-LO inhibitory effects, but exhibited less activity 
towards XO.  
CYP3A4 is an important-drug metabolizing enzyme, and any change of its activity may lead 
to pharmacokinetic interactions. Aronia substances were investigated for their CYP3A4 
inhibitory effects, and it was shown that procyanidin B5 and subfraction Seph g, rich in 
proanthocyanidins with a high degree of polymerization, were potent inhibitors of this protein. 
In addition, the inhibitory activity of proanthocyanidin-containing subfractions was correlated 
to the degree of polymerization of these substances. 
The formation of bacterial biofilms is a well known health problem, as bacteria within such a 
structure are more difficult to eradicate. Aronia substances were added to planktonic cultures 
of Escherichia coli and Bacillus cereus in order to measure their influence on biofilm 
formation. Results showed that the majority of the samples possessed a biofilm inhibitory 
activity against the Gram-positive B. cereus, but fewer samples were active against the Gram-
negative E.coli. 
Minor differences in chemical structure, for example between procyanidin B2 and B5, gave 
rise to considerable differences in biological activities such as CYP3A4 inhibition and 
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inhibition of biofilm formation. Also, biological activity seemed to be influenced by the sugar 
unit linked to the anthocyanidin. 
Four different cultivars of aronia were studied with respect to their phenolic composition and 
their biological activities. Aronia prunifolia contained the highest amount of total phenolics, 
anthocyanins, and proanthocyanidins. Despite the differences in chemical composition 
between the cultivars, which could be explained at least partly by unequal growing conditions, 
only minor differences in biological activity were found.                
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1 Introduction 
1.1 Project background 
The motivation to start this project was based on observations made in a nursing home for the 
elderly in Hå, Norway. In 2005 one floor at the Hå elderly care facility started to serve their 
residents a beverage made from aronia berries as a replacement to other drinks. The drink 
became popular and they kept on serving it until the end of 2007. During this two year period, 
employees noticed that the incidents of urinary tract and pneumonia infections were reduced. 
Also, the residents reported an increased sense of well-being. Another pleasant surprise was 
the complete disappearance of urine smell at this floor shortly after the introduction of the 
new beverage. However, this was not a clinical study and no scientific approach was taken to 
verify the observations (Slimestad, R., personal communication).  
This is a collaboration project between Bioforsk Vest Særheim, Tine SA, and the Department 
of Pharmaceutical Chemistry, School of Pharmacy, University of Oslo. It is part of a project 
entitled “Potential of black aronia berries (Aronia melanocarpa) in treatment of urinary tract 
infections”, funded by the Research Council of Norway.     
1.2 Aronia plants 
Aronia, also called chokeberry, is a member of the Rosaceae family. The genus is usually 
considered to contain two species: Black chokeberry, Aronia melanocarpa (Michx.) Ell., and 
red chokeberry, Aronia arbutifolia (L.) Pers. (Kokotkiewicz et al., 2010; Kulling and Rawel, 
2008). Purple chokeberry, Aronia prunifolia, is regarded as a hybrid between A. melanocarpa 
and A. arbutifolia, it is however ambiguous if it should rather be considered a distinct species. 
Aronia prunifolia (Marshall) Rehder is indexed in The International Plant Names Index 
(International Plant Names Index, 2013). 
Shrubs of the Aronia genus are native North American plants that have been traditionally used 
in Native American medicine, for example in the treatment of colds (Kokotkiewicz et al., 
2010; Kulling and Rawel, 2008). The aronia shrubs can grow to a height of 2-3 m, they 
produce in May to June umbels of small white flowers, ripening to red (red chokeberry) or 
purple-black berries (purple and black chokeberry). In the 20th century, aronia became popular 
in the Soviet Union and in different parts of Europe, and the plants were cultivated either for 
their ornamental value or to use the berries as a food ingredient. The aronia plant has become 
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even more popular in recent years due to its berries having a high content of polyphenols with 
antioxidant activity (see section 1.2.1 and 1.2.2). Aronia products are well received as  
nutritional supplements, and the berries are also used as an ingredient for juices, wines, jams, 
and as a source of natural food colorants (Kulling and Rawel, 2008). 
  
Figure 1. Aronia melanocarpa, cultivar “Moskva”. 
 
Cultivars used for fruit production are from the species Aronia melanocarpa. Commercially 
important cultivars in Europe and the United States include “Aron”, “Nero”, “Viking”, 
“Hugin” and “Rubina” (Kulling and Rawel, 2008). In Norway, the cultivar “Moskva” is most 
common (Figure 1).      
1.2.1 Phenolic constituents of aronia berries 
It has been suggested that the most important constituents present in aronia, also responsible 
for many of its putative medical properties are the phenolic compounds (Kokotkiewicz et al., 
2010; Kulling and Rawel, 2008). Aronia berries contain high levels of procyanidins, 
anthocyanins and phenolic acids. Procyanidins have been identified as the major class of 
polyphenolic compounds in chokeberries (Oszmiański and Wojdylo, 2005). Their content 
varies from 0.7% to 5.2% dry weight (Kokotkiewicz et al., 2010; Oszmiański and Wojdylo, 
2005). Aronia plants contain exclusively B type procyanidins with (-)-epicatechin as the main 
monomer subunit (Kulling and Rawel, 2008; Oszmiański and Wojdylo, 2005). The degree of 
polymerization (DP) of procyanidins varies from 2 to 23 units in the fruits, with clear 
domination of >decamers fraction (Kokotkiewicz et al., 2010). Free epicatechin is also 
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present in chokeberries, although its concentration is significantly lower in comparison with 
polymeric procyanidins. In aronia berries, anthocyanins constitute the second largest group of 
phenolic compounds, with a concentration range from 0.6% to 2.0% dry weight. The 
anthocyanins in A. melanocarpa are mainly a mixture of four cyanidin glycosides: cyanidin 3-
galactoside, cyanidin 3-glucoside, cyanidin 3-arabinoside and cyanidin 3-xyloside; of those 
cyanidin 3-galactoside is present in the highest concentration. Also, chokeberries constitute a 
rich source of phenolic acids. Chlorogenic and neochlorogenic acids were the two dominating 
phenolic acids identified in the fruits (Slimestad et al., 2005). A series of factors, such as 
habitat/location, harvest date, cultivar, fertilization, and maturation of the berries can affect 
their content (Jeppsson and Johansson, 2000; Rop et al., 2010; Skupień and Oszmiański, 
2007). 
1.2.2 Potential health benefits of aronia berries 
Many beneficial health effects have been studied for aronia berry juice, nectar, extracts and 
for some isolated compounds. The berries have a wide range of potential medicinal and 
therapeutic effects; however, the amount of data on human clinical studies is limited, and 
most of the reported pharmacological activities were obtained from in vitro studies. 
Nevertheless, there are several papers available from studies in rats (Kokotkiewicz et al., 
2010; Kulling and Rawel, 2008). This section focuses on the most important in vitro and in 
vivo findings reported regarding biological effects of black chokeberries.  
The antioxidant properties of aronia juice, extracts and its phenolic constituents have been 
reported in a series of papers, using different well established in vitro assays (Kokotkiewicz et 
al., 2010; Kulling and Rawel, 2008; Valcheva-Kuzmanova and Belcheva, 2006). So far, fresh 
aronia berries possess the highest antioxidant activity among common berries and fruits when 
measured with the oxygen radical absorbance capacity (ORAC) assay (Kulling and Rawel, 
2008; Zheng and Wang, 2003). A few reports also describe an antioxidant effect in animal 
models, where chokeberry anthocyanins decreased lipid peroxidation and enhanced the 
activity of enzymes which are involved in the antioxidant defense system (Faff and 
Frankiewicz-Jozko, 2003; Kowalczyk et al., 2004). An antioxidant activity was also found in 
humans, as a dietary supplementation with aronia juice limited the exercise-induced oxidative 
damage to red blood cells in rowers (Pilaczynska-Szczesniak et al., 2005).  
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Aronia berries may also have a positive influence on several risk factors associated with 
cardiovascular diseases (Kokotkiewicz et al., 2010; Kulling and Rawel, 2008). The lipid-
lowering activity of aronia preparations has been well documented with use of rat models. 
Administration of A. melanocarpa juice to hyperlipidaemic rats resulted in substantially 
decreased levels of total cholesterol, low-density lipoprotein (LDL) cholesterol and 
triglycerides in blood plasma (Valcheva-Kuzmanova et al., 2007 a; Valcheva-Kuzmanova et 
al., 2007 b). In men with a mild hypercholesterolaemia, regular chokeberry juice drinking 
(250 mL per day) for six weeks resulted in a significant decrease in serum total cholesterol, 
LDL cholesterol and triglyceride level, whereas the HDL2 cholesterol level was increased 
(Skoczyńska et al., 2007). Another study showed that combination therapy of statins with a 
flavonoid-rich extract from chokeberry fruits enhanced reduction in cardiovascular risk 
markers in patients after myocardial infraction, and a lowering of systolic and diastolic blood 
pressure in persons supplemented with the extract was also reported (Naruszewicz et al., 
2007). In addition, other studies have demonstrated an anti-diabetic activity of aronia juice 
both in diabetic rats (Valcheva-Kuzmanova et al., 2007 c) and in non-insulin dependent 
diabetic humans (Simeonov et al., 2002), showing that aronia might be useful in the 
prevention and control of diabetes mellitus type II and diabetes-associated complications. 
Phenolic compounds isolated from berries of Aronia melanocarpa showed antimutagenic 
activities in vitro (Gąsiorowski et al., 1997). The Ames test and the sister chromatid exchange 
assay with cultured human lymphocytes revealed that anthocyanins isolated from black 
chokeberries possess antimutagenic activity. Also, several reports suggest anti-proliferative or 
protective effects of chokeberry juice and anthocyanin-rich chokeberry extracts against colon 
cancer on the basis of in vitro studies (Bermudez-Soto et al., 2007; Malik et al., 2003; Zhao et 
al., 2004) and an animal study (Lala et al., 2006).  
Animal studies in rats also report hepatoprotective effects of A. melanocarpa (Kowalczyk et 
al., 2003; Valcheva-Kuzmanova et al., 2004). In one study, anthocyanins from chokeberry 
decreased the toxicity and accumulation of cadmium in the liver and kidney of rats receiving 
both these components in their diet. The reduction in harmful effects from cadmium could be 
explained by the anthocyanins ability to chelate metal ions (Kowalczyk et al., 2003). In 
another experiment, a hepatoprotective effect of aronia juice was observed in rats after acute 
exposure to carbon tetrachloride (Valcheva-Kuzmanova et al., 2004). The protective effect of 
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A. melanocarpa seems to be related to its antioxidative properties and the scavenging of free 
radicals formed during carbon tetrachloride intoxication.  
Antimicrobial properties of phenolic compounds from numerous berry species, such as 
cranberry, blueberry, and raspberry are well known and have been demonstrated in vitro. 
Aronia melanocarpa fruit juice exhibited bacteriostatic activity in vitro against 
Staphylococcus aureus and Escherichia coli, and possessed an antiviral activity against 
influenza virus type A (Valcheva-Kuzmanova and Belcheva, 2006). 
Besides potential health benefits of natural products, it is equally important to be aware of 
potential adverse effects associated with consumption of these products. Currently, there are 
no data in the literature about any unwanted or toxic effects of Aronia melanocarpa berries, 
juice or extracts.      
1.2.3 Bioavailability of aronia polyphenols 
The extent of the potential benefits associated with the antioxidant effects of polyphenols as 
well as other positive health effects studied in vitro are dependent in vivo on the absorption, 
metabolism, distribution, and excretion of these compounds within the body after ingestion 
(Denev et al., 2012). Therefore, bioavailability studies allowing the determination of the real 
exposure of the human organism to the tested compounds are essential. Bioavailability 
appears to differ greatly among the various phenolic compounds and metabolism is a factor 
strongly affecting their plasma concentrations. After absorption, polyphenols are usually 
subjected to three main types of conjugation: methylation, sulfation, and glucuronidation. 
The bioavailability of anthocyanins from aronia has been investigated more thoroughly than 
the bioavailability of the other phenolic constituents, because of their simple profile (Denev et 
al., 2012). Only small amounts of the anthocyanins are absorbed in the small intestine, thus 
significant amounts are likely to enter the colon where bacterial degradation occurs (Pascual-
Teresa et al., 2010). Anthocyanins are some of the few polyphenols that can be detected 
unmetabolized (e.g. as glycosides) in plasma. However, bioavailability data of aronia 
anthocyanins give controversial information (Denev et al., 2012). There are big differences in 
the number of recovered metabolites in blood and urine and the amounts of recovered parent 
anthocyanins in the human and animal studies. The major finding in the bioavailability studies 
of aronia anthocyanins was the determination of nanomolar concentrations in blood and urine. 
They can undergo glucuronidation and methylation, whereas sulfation was not observed. It 
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appears likely that these metabolic products are partly responsible for the reported health 
benefits associated with the consumption of anthocyanins. 
So far, neither the flavanols nor the proanthocyanidins isolated from aronia have been 
subjected to bioavailability studies. The intake of monomeric flavanols with aronia berries is 
low and it is not very likely that they have a significant influence on plasma polyphenol 
concentrations (Denev et al., 2012). Generally, low molecular weight oligomeric 
proanthocyanidins (DP ≤ 3) are absorbed intact in the gastrointestinal tract (GIT), but 
polymerization greatly impairs intestinal absorption (Denev et al., 2012; Pascual-Teresa et al., 
2010). Most pass to the colon unaltered where they are catabolized by the colonic microflora, 
yielding a diversity of phenolic acids including 3-(3-hydroxyphenyl)-propionic acid and 4-O-
methylgallic acid. Those can be absorbed into the circulatory system and excreted in urine. 
Despite their poor absorption, proanthocyanidins may exert a local activity in the 
gastrointestinal tract or an activity mediated by phenolic acids produced through microbial 
degradation. Their local action may nevertheless still be of importance because the intestine is 
for example particularly exposed to oxidizing agents and may be affected by inflammation 
and numerous diseases, including cancer.  
Phenolic acids, when ingested in the free form, are rapidly absorbed from the small intestine 
(Denev et al., 2012). However, the main representatives in aronia, chlorogenic and 
neochlorogenic acids are naturally esterified and this impairs their absorption. 
Ironically, the polyphenols which are present in the highest amounts in chokeberries 
(anthocyanins and proanthocyanidins) are the least well absorbed. Nevertheless, there is 
accumulated experimental evidence of the effectiveness of aronia products in a broad range of 
pathological conditions (see section 1.2.2) in many cases mediated by uncontrolled oxidative 
processes. The first site of action of chokeberry polyphenols is the gastrointestinal tract where 
they and their metabolites released by the gut microflora could act for example as antioxidants. 
1.3 Chemistry of isolated compounds 
1.3.1 Polyphenols 
Polyphenols are common constituents of plant-based foods (Tsao, 2010). Fruits, vegetables, 
whole grains and other types of foods and beverages such as tea, chocolate and wine are rich 
sources of polyphenols. They are chemically characterized as compounds with a polyphenol 
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structure (e.g. several hydroxyl groups on aromatic rings), but molecules with one phenol ring, 
such as phenolic acids and simple phenols, are also often included (D’Archivio et al., 2007). 
This group of natural products is very diverse and contains several sub-groups of phenolic 
compounds, which differ by the number of phenol rings that they contain and by the structural 
elements that bind these rings to one another (D’Archivio et al., 2007; Tsao, 2010). The main 
groups of polyphenols are: flavonoids, phenolic acids, simple phenols, stilbenes and lignans.  
1.3.2 Flavonoids 
Flavonoids are polyphenolic compounds comprising 15 carbons, with two aromatic rings 
connected by a three carbon bridge, hence C6–C3–C6 (Figure 2). They are the most numerous 
of the phenolics and are found throughout the plant kingdom (Crozier et al., 2009). They act 
in plants as antioxidants, antimicrobials, photoreceptors, visual attractors, feeding repellents, 
and screens against UV irradiation (Alzand and Mohamed, 2012). Flavonoids occur widely in 
the fruits and vegetables that are part of the human diet and it has been estimated that at least 
one gram of flavonoids is consumed daily (Pascual-Teresa et al., 2010). A number of 
biological and pharmacological activities have been reported for flavonoids, including 
antioxidant, cytotoxic, anticancer, antiviral, antibacterial, cardioprotective, hepatoprotective, 
neuroprotective, and antimalarial properties (Alzand and Mohamed, 2012). The main sub-
classes of dietary flavonoids are flavonols, flavones, flavan-3-ols, anthocyanidins, flavanones 
and isoflavones, while those that are comparatively minor components of the diet are 
dihydroflavonols, flavan-3,4-diols, chalcones, dihydrochalcones and aurones (Crozier et al., 
2009). Each group of flavonoids possesses unique chemical properties and has a particular 
distribution in plants (Alzand and Mohamed, 2012). 
 
Figure 2. Flavonoid skeleton. 
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1.3.3 Flavanols and proanthocyanidins 
Catechins are classified as flavan-3-ol monomers and are characterized by a C6-C3-C6 
skeleton with a hydroxyl group in position three of the C-ring, two chiral centers on the 
molecule (one on carbon two and one on carbon three) and no oxygen atom linked to carbon 
four (Pascual-Teresa et al., 2010). The two compounds catechin and epicatechin are well 
known flavonoids with a widespread distribution (Figure 3). Catechin, epicatechin, 
gallocatechin, epigallocatechin and their galloyl substituted derivatives are commonly found 
in plant-derived foods and food products. Monomeric flavanols are the biosynthetic 
precursors of proanthocyanidins, also called condensed tannins.  
  
Figure 3. Structures of catechin and epicatechin. 
 
Proanthocyanidins are found mainly in fruits, berries, beans, nuts, cocoa, and wine 
(Rasmussen et al., 2005). Through the formation of complexes with salivary proteins, 
proanthocyanidins are responsible for the astringent character of fruits and beverages (e.g. 
wine) and for the bitterness of chocolate. Condensed tannins are oligomers (dimers to 
pentamers) or polymers (six or more units) of flavan-3-ols (Pascual-Teresa et al., 2010). 
Proanthocyanidins that exclusively consist of (epi)catechin units are designated procyanidins, 
whereas proanthocyanidins containing (epi)afzelechin or (epi)gallocatechin subunits are 
called propelargonidins or prodelphinidins, respectively (Rasmussen et al., 2005). The most 
common oligomers are the B series, B1 to B8, formed by two flavanol units, either catechin or 
epicatechin, joined by a C4-C8 linkage (B1 to B4), or C4–C6 linkage (B5 to B8). The least 
frequent dimers are the A series, characterized by the presence of double linkages between the 
two flavanol units, one C4-C8 or C4-C6 and an additional one between C2 and C5 or C7. 
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Type A proanthocyanidins are less common in food plants; however their presence in peanuts, 
almond skins and in some berries such as cranberries has been reported (Pascual-Teresa et al., 
2010). 
1.3.4 Anthocyanins 
Anthocyanins are water-soluble pigments responsible for the blue, purple, red and orange 
colors of many fruits and vegetables (Pascual-Teresa et al., 2010). More than 500 different 
anthocyanins have been described in the literature, and many reports of new anthocyanin 
structures have been published during the last decade. This can partly be explained by the use 
of improved analytical techniques, but also due to their impact on the sensorial characteristics 
of food products and their potential use as health beneficial compounds. The anthocyanins 
consist of an aglycone (anthocyanidin), sugar(s), and in many cases acyl group(s). They are 
positively charged at acidic pH, and this equilibrium form is called flavylium cation (2-
phenylbenzopyrylium). Several anthocyanidins (aglycone forms) have been reported with 
hydroxyl and methoxyl groups present at different positions on the basic structure. Six of 
them are commonly found in fruits and vegetables: pelargonidin, cyanidin, peonidin, 
delphinidin, petunidin, and malvidin (Figure 4).    
             
Figure 4. Structures of the most common anthocyanidins. 
 
1.3.5 Phenolic acids 
Phenolic acids are aromatic secondary plant metabolites, widely spread throughout the plant 
kingdom (Robbins, 2003). In general, the name phenolic acid describes phenols that possess 
one carboxylic acid functionality. However, when describing plant metabolites, it refers to a 
distinct group of organic acids. These naturally occurring phenolic acids contain two common 
carbon frameworks: the C6-C3 hydroxycinnamic and C6-C1 hydroxybenzoic structures, 
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which constitute some of the main non-flavonoid polyphenolic compounds of dietary 
significance. Although the basic skeleton remains the same, the numbers and positions of the 
hydroxyl groups on the aromatic ring create the variety. The most common 
hydroxycinnamates are p-coumaric acid, caffeic acid, ferulic acid and sinapic acid, with 
caffeic acid dominating (Crozier et al., 2009). These often occur as conjugates, for example 
with tartaric acid or quinic acid. The quinic acid conjugates are usually referred to as 
chlorogenic acids. Among the hydroxybenzoic acids, gallic acid is the most common.  
1.4 Biological activities 
1.4.1 Free radicals and antioxidant activity 
A free radical is any species capable of independent existence that contains one or more 
unpaired electrons in its outer orbital (Lobo et al., 2010). Many radicals are unstable and 
highly reactive, and can cause oxidative damage to biologically relevant molecules such as 
DNA, proteins, carbohydrates, and lipids. Free radicals and other reactive oxygen species 
(ROS) are continuously produced in vivo as a consequence of both enzymatic and non-
enzymatic reactions, but are also derived from external sources such as exposure to radiation, 
cigarette smoking, air pollutants, and industrial chemicals. The term oxidative stress is used to 
describe the condition of oxidative damage resulting when the balance between free radical 
generation and antioxidant defenses is disrupted. Oxidative stress is a physiological state, 
which has been suggested to be an important factor for the development of many diseases 
including cardiovascular diseases, stroke, and neurodegenerative disorders such as 
Alzheimer's disease and Parkinson's disease (Denev et al., 2012). 
An antioxidant has been defined as a substance that when present at low concentrations 
compared to those of an oxidizable substrate, significantly delays or prevents oxidation of that 
substrate (Frankel and Meyer, 2000). Testing of antioxidant activities of natural products and 
their potential beneficial effects on health has received much attention in recent years. The 
antioxidant capacity of natural substances can be assessed with numerous assays. Due to the 
complexity of the composition of phytochemicals and of the oxidative processes, it is 
recommended to use more than one method in order to evaluate the total antioxidant activity 
(Denev et al., 2012; Frankel and Meyer, 2000; Wangensteen et al., 2004).   
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1.4.1.1 Scavenging of the 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical 
Scavenging of the 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical is a very rapid and easy to 
perform method for antioxidant activity testing (Denev et al., 2012). The assay is based on the 
use of the stable free DPPH radical (Figure 5) which has a deep violet color with a UV–
visible absorption maximum in methanol or ethanol solutions at around 515-520 nm (Huang 
et al., 2005; Molyneux, 2004). Upon scavenging of the radical by an antioxidant, the solution 
color fades and the reaction progress is conveniently monitored by a spectrophotometer. On 
the basis of the chemical reactions involved, antioxidants can deactivate radicals by hydrogen 
atom transfer (HAT) or by electron transfer (ET) reactions (Denev et al., 2012). The DPPH 
assay was believed to involve hydrogen atom transfer reactions (Huang et al., 2005; 
Molyneux, 2004), but other studies have suggested otherwise (Foti et al., 2004; Litwinienko 
and Ingold, 2004). On the basis of the kinetic analysis of the reaction between phenols and 
DPPH, it was suggested that an ET mechanism is favored in the reaction between phenols 
having low pKa values and DPPH in strong hydrogen-bond-accepting solvents, such as 
methanol and ethanol. 
 
Figure 5. Scavenging of the DPPH radical. Both, the hydrogen atom transfer (HAT, upper picture) 
and electron transfer (ET, lower picture) have been proposed as scavenging reaction mechanisms (Foti 
et al., 2004; Litwinienko and Ingold, 2004). 
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1.4.1.2 Inhibition of 15-lipoxygenase (15-LO) 
Lipoxygenases (LOs) are non-heme iron-containing enzymes that catalyze specific lipid 
peroxidations and are found in plants, animals, and some bacteria (Funk, 2006; Kühn et al., 
2005). Mammalian lipoxygenases may be classified into four different subfamilies (Figure 6), 
originally divided into  5-, 8-, 12-, and 15-LO, and named for the numbered carbon where 
they oxygenate arachidonic acid (Dobrian et al., 2011; Kühn et al., 2005; Takahashi et al., 
2005). Based on the phylogenetic relatedness an alternate classification for mammalian 
lipoxygenases is proposed, comprising 5-LO, 12/15-LO, platelet-type 12-LO, and epidermal-
type LO (Kühn et al., 2005). Among these subclasses, 5-, 12- and 15-LO have been 
implicated in the development of atherosclerosis. When arachidonic acid is metabolized, all of 
the different LO isoforms generate lipid hydroperoxides (HPETEs) as the primary product 
(Dobrian et al., 2011). Those are rapidly reduced intracellularly to their corresponding 
hydroxides (HETEs). In humans, 12/15-LOs create a number of important lipid mediators, 
such as 12- and 15-HPETEs and 12- and 15-HETEs. These lipid products have a variety of 
functions in human tissues, for example they are involved in monocyte binding in the 
vasculature, an early event in atherogenesis. Other potential mechanisms for the atherogenic 
promoting role of 15-LO is its ability to oxidize LDL and HDL (Funk, 2006; Kühn et al., 
2005). It has also been shown that 12- and 15-LO and their metabolites are important in a 
variety of other pathological conditions, such as diabetes (both types I and II), renal disease, 
obesity, and various diseases of the central and peripheral nervous systems (Dobrian et al., 
2011). The development of selective LO inhibitors may be useful to treat these disorders in 
the future. However, the precise role of these enzymes is still under discussion and an active 
area of investigation, as conflicting biological functions of 12- and 15-LO have been reported 
(Dobrian et al., 2011; Kühn et al., 2005). Those enzymes were shown to possess both pro-
atherogenic (in mice) and anti-atherogenic (in rabbits) effects. Also, 15-lipoxygenase may 
generate lipoxins with anti-inflammatory activity.  
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Figure 6. Subclassification of mammalian lipoxygenase isoforms, originally divided based on their 
ability to insert molecular oxygen at the corresponding carbon position of arachidonic acid (left). 
Recently, an alternate classification according to their phylogenetic relatedness has been proposed 
(right). Isoforms on gray background have been implicated in cardiovascular diseases (Kühn et al., 
2005; Takahashi et al., 2005).  
 
1.4.1.3 Inhibition of xanthine oxidase (XO) 
Xanthine oxidase (XO) is a form of xanthine oxidoreductase, found mainly in the liver and 
gastrointestinal tract, but also in the kidney, brain and throughout the cardiovascular system 
(Higgins et al., 2009; Pacher et al., 2006). The primary role of this enzyme is the conversion 
of hypoxanthine to xanthine, and xanthine to uric acid (Figure 7). Elevated levels of uric acid 
in the blood can cause hyperuricemia, which is associated with gout and kidney stones 
(Akowuah et al., 2006), but has also been linked to other pathological states such as 
cardiovascular diseases (Higgins et al., 2009). The purine analogue allopurinol is a clinically 
used XO inhibitor in the treatment of gout and hyperuricemia, but this drug suffers from many 
side effects such as hepatitis, nephropathy, and allergic reactions (Nguyen et al., 2004; Pacher 
et al., 2006). Thus, novel XO inhibitors with increased therapeutic activity and fewer side 
effects are desired. The action of XO enzymes also generates superoxide radicals and 
hydrogen peroxide, which can add to or initiate oxidative stress (Higgins et al., 2009; Pacher 
et al., 2006). Hence, the inhibition of xanthine oxidase may not only be beneficial to treat 
gout and hyperuricemia but could also be useful to combat other diseases associated with 
oxidative stress.   
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Figure 7. Xanthine oxidase (XO) catalyzes the oxidation of hypoxanthine to xanthine and can further 
catalyze the oxidation of xanthine to uric acid. 
 
1.4.2 α-Glucosidase inhibitory activity 
Carbohydrates constitute an important part of the human diet, however, only monosaccharides, 
such as glucose and fructose, can be absorbed by the small intestine (Coniff and Krol, 1997). 
Polysaccharides and disaccharides (e.g. starch and sucrose) undergo rapid enzymatic 
degradation to monosaccharides in the upper intestine through the action of pancreatic α-
amylase and α-glucosidase. α-Glucosidase is a membrane bound enzyme located in the brush 
border of the small intestine (Huang et al., 2010). It is the key enzyme during the final step in 
the digestive process of carbohydrates, as it catalyzes the cleavage of glucose from 
oligosaccharides and disaccharides. Inhibition of α-glucosidase in the intestine decreases the 
rate of hydrolytic cleavage of saccharides and the process of carbohydrate digestion spreads to 
the lower part of the small intestine (Kumar et al., 2011). This spreading of the digestive 
process delays the overall absorption rate of glucose into the blood and has proved to be a 
good strategy to reduce postprandial plasma glucose levels and suppress postprandial 
hyperglycemia, which might help to prevent the onset of diabetes or long-term diabetic 
complications. The α-glucosidase inhibitor acarbose is the active principle in an anti-diabetic 
drug used to treat type II diabetes mellitus and is effective in patients having a diet relatively 
rich in carbohydrates (Coniff and Krol, 1997). In recent years, many efforts have been made 
to identify effective α-glucosidase inhibitors from natural sources in order to develop a 
physiologic functional food or lead compounds for use against diabetes (Kumar et al., 2011). 
1.4.3 Cytochrome P450 3A4  
Cytochrome (CYP) P450 enzymes are responsible for the metabolism of endogenous 
components and xenobiotics, such as pharmaceuticals and environmental compounds 
(Shimada et al., 1994). There are several drug-metabolizing CYPs, but the most abundantly 
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expressed isoform is CYP3A4, which is responsible for the metabolism of more than 50% of 
medicinal products on the market, for example calcium-channel blockers, statins, and 
cyclosporine (Ansede and Thakker, 2004; Kimura et al., 2010). CYP3A4 is located in the 
small intestine (found in the apical enterocytes) and liver, which makes it well suited to play a 
significant role in presystemic drug metabolism (Dresser and Bailey, 2003). Serious 
interactions have occurred as a result of the induction or the inhibition of the cytochrome 
P450 enzymes, since coadministration of multiple CYP3A4 substrates with inducers or 
inhibitors may alter pharmacokinetic parameters of many commonly prescribed drugs 
(Dresser and Bailey, 2003; Harris et al., 2003). Interactions between components in food or 
herbal supplements and medicines have come into focus as there are numerous examples of 
metabolic interactions involving modulation of CYP activity by dietary substances. A 
prominent example of food-drug interactions mediated by CYP3A4 is provided by the 
inhibitory effects of furanocoumarins in grapefruit juice on presystemic metabolism, 
particularly in the intestine, leading to increased drug bioavailability. Also, the interaction 
between components of St. John’s wort (Hypericum perforatum) and various pharmaceuticals 
by induction of CYP3A4 leading to reduced drug concentrations in blood is well known 
(Dresser and Bailey, 2003; Harris et al., 2003; Kimura et al., 2010). Similarly to the grapefruit 
juice interaction, the St John’s wort interaction may be more profound with orally 
administered compounds that undergo significant presystemic metabolism.  
1.4.4 Antimicrobial activity 
Pathogenic microorganisms can cause infection and disease in humans, animals and plants. 
Most microbes belong to four major groups: bacteria, viruses, protozoa or fungi. The 
development of antibiotics has been an important achievement in medicine; however, 
infectious diseases are still of major medical and scientific concern (Yoneyama and 
Katsumata, 2006). There is a pressing need for new antibiotics due to the inevitable 
development of resistance that follows the introduction of antibiotics to the market. Much of 
the exploration and utilization of natural products as antimicrobials arise from microbial 
sources (Cowan, 1999). Compounds such as plant metabolites that serve as a defense 
mechanism against the attack of bacteria and fungi also constitute a potential source of new 
antimicrobial drugs. Nevertheless, the development of antimicrobial agents from plant 
products has been extremely limited.  
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1.4.4.1 Disk diffusion method 
A variety of laboratory methods can be used to measure the in vitro susceptibility of 
microorganisms to different test compounds (CLSI document M2-A9; Cos et al., 2006; 
Jorgensen and Ferraro, 2009). The disk diffusion assay is simple and practical and has been 
well-standardized for common, rapidly growing pathogens, and also for certain fastidious 
ones. Currently, the Clinical Laboratory Standards Institute (CLSI) is responsible for updating 
and modifying this procedure through a global consensus process to ensure uniformity of 
technique and reproducibility of results. In the diffusion method, a reservoir containing the 
test compound at a known concentration is brought into contact with an inoculated medium 
and the diameter of the clear zone around the reservoir (inhibition diameter) is measured at 
the end of the incubation period. The diameter of the zone is related to the susceptibility of the 
pathogen and to the diffusion rate of the compound through the agar medium. Disk diffusion 
testing does not provide quantitative results such as minimum inhibitory concentration. 
Results of this method are qualitative, in that a category of susceptibility (susceptible, 
intermediate or resistant) is derived from the test. This assay is not appropriate for testing 
non-polar samples or samples that do not easily diffuse into agar. The relative antimicrobial 
potency of different substances is not always comparable, mainly because of differences in 
physical properties (e.g. solubility, volatility and diffusion characteristics in agar). 
1.4.4.2 Inhibition of biofilm formation 
Bacterial biofilms are sessile communities with high cell density embedded within a self-
produced matrix of extracellular polymeric substance (EPS) that are ubiquitous in natural, 
medical, and engineering environments (Estrela and Abraham, 2010; Ren et al., 2005). 
Biofilm formation is a key factor for microbial survival in hostile environments, representing 
a protected mode of growth that allows cells to survive and disperse. Deleterious biofilms are 
problematic in the industry since they cause fouling and corrosion in systems such as heat 
exchangers, oil pipelines, and water systems. Biofilms have been found to be involved in a 
wide variety of microbial infections in the body. They can colonize indwelling medical 
devices (e.g. cause catheter-related infections), but are also involved in common problems 
such as urinary tract, middle-ear and oral (e.g. dental plaque and gingivitis) infections and 
have been linked to chronic diseases such as lung infections in cystic fibrosis (Parsek and 
Singh, 2003). Bacteria in a biofilm are more likely to survive antibiotics than planktonic (free 
swimming) cells and are often responsible for reoccurring symptoms and medical treatment 
17 
 
failure (Estrela and Abraham, 2010; Ren et al., 2005). There are many reasons for the higher 
antibiotic resistance of bacteria in a biofilm, for example their genetic program (gene 
expression) within such a structure is fundamentally changed. They grow slower and the 
reduced metabolic activity renders them less prone against most antibacterial drugs. Also, 
some protection may be conferred by the physical barrier provided by the presence of the EPS 
that covers the biofilm and may prevent sufficient antibiotic exposure to kill the cells. 
Recently, there has been a tremendous increase in biofilm research, most of it aiming at the 
prevention, control, and eradication of biofilms. An important focus of this research has been 
the development of alternative approaches, either to avoid the use of antimicrobial drugs 
altogether, or to combine alternative treatments with more traditional antimicrobial drugs. 
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2 Aims of the study 
A consensus has developed over the last few decades that the health promoting effects 
associated with a diet rich in fruits and vegetables may be derived, in part, from the intake of 
natural antioxidants, such as vitamin C and polyphenols. Interest in the health benefits of 
aronia berries is based on their very high levels of flavonoids and other phenolic compounds, 
in addition to the surprisingly positive effects observed at the Hå nursing home after aronia 
berry juice was served instead of other beverages (see section 1.1).  
The main objectives of the thesis were: 
1. To isolate and elucidate the structure of some of the main bioactive polyphenols in 
aronia berries (paper I). 
2. To measure in vitro antioxidant activity of aronia extracts, fractions and compounds. A 
large proportion of the ingested polyphenols will not be taken up into the circulation 
and passes through the upper gastrointestinal tract to the large intestine. Investigation 
of their effects in the gut is therefore highly relevant. The inhibitory activities of black 
chokeberry substances were also tested on the digestive enzyme, α-glucosidase, 
which is present in the small intestine (paper I and IV). 
3. To study the effects of aronia substances on the activity of the metabolic enzyme 
CYP3A4 in order to provide more information on the food-drug interaction potential 
(paper II). 
4. To investigate the inhibition of biofilm formation and the antibacterial activity of 
aronia berry extracts, fractions and compounds thereof on Escherichia coli and 
Bacillus cereus (paper III). 
5. To compare four cultivars of Aronia with respect to their phenolic composition as well 
as their biological activities (paper IV).       
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3 Summary of papers 
 
Paper I. Extracts, anthocyanins and procyanidins from Aronia melanocarpa as radical 
scavengers and enzyme inhibitors  
In this study the four main anthocyanins (cyanidin 3-galactoside, cyanidin 3-glucoside, 
cyanidin 3-arabinoside and cyanidin 3-xyloside) and three procyanidins (dimers B2 and B5 
and trimer C1) were isolated from Aronia melanocarpa, cultivar “Moskva”. The compounds 
were identified on the basis of their chromatographic and spectroscopic data (TLC, HPLC, 
LC-MS). In addition, crude extracts and subfractions were obtained from the berries. NMR 
analysis revealed that proanthocyanidins were present in the 50% EtOH extract. Subfractions 
of this extract were further shown to consist mainly of proanthocyanidins with epicatechin 
stereochemistry. The substances were investigated for their antioxidant and α-glucosidase 
inhibitory activities. Subfractions rich in procyanidins were found to be potent α-glucosidase 
inhibitors; they possessed high radical scavenging properties, a strong inhibitory activity 
towards 15-LO and a moderate inhibitory activity towards XO. Trimeric procyanidin C1 
showed higher activity in the biological assays compared to the dimeric procyanidins B2 and 
B5. Also, the activity of the anthocyanins was found to be influenced by the sugar units linked 
to the anthocyanidin.  
Paper II.  In vitro inhibition of cytochrome P450 3A4 by Aronia melanocarpa 
constituents.  
The aim of this work was to investigate the effects of crude extracts, subfractions, and 
compounds found in aronia on CYP3A4 activity in order to determine the potential risk of 
food-drug interactions. Midazolam was used as the probe substrate and recombinant insect 
cell microsomes expressing CYP3A4 as the enzyme source. In this assay, several constituents 
of A. melanocarpa possessed CYP3A4 inhibitory activity. Procyanidin B5 was a considerably 
stronger CYP3A4 inhibitor in vitro than the isomeric procyanidin B2 and comparable to 
bergamottin, a known CYP3A4 inhibitor from grapefruit juice. The inhibitory activity of 
proanthocyanidin-containing subfractions was correlated to the degree of polymerization. For 
the anthocyanins, the ability to inhibit CYP3A4 in vitro seemed to be influenced by the sugar 
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unit linked to the anthocyanidin. The phenolic acids (chlorogenic and neochlorogenic acid), 
however, did not inhibit CYP3A4-mediated midazolam metabolism.  
Paper III. Effects of Aronia melanocarpa constituents on biofilm formation of 
Escherichia coli and Bacillus cereus 
This study aimed to evaluate the ability of A. melanocarpa extracts, subfractions and 
compounds to prevent biofilm formation on PVC microtitre plates and to inhibit bacterial 
growth of Escherichia coli and Bacillus cereus. It was found that the majority of the samples 
displayed biofilm inhibition against the Gram-positive B. cereus at concentrations of 1 mg/mL, 
but exhibited less activity against the Gram-negative E. coli. However, the dichloromethane 
(DCM) extract and epicatechin that showed no anti-biofilm activity against B. cereus were 
effective against E. coli. In fact, epicatechin was the most active against biofilm-producing E. 
coli, whereas the 50% EtOH extract displayed the most potent biofilm inhibition against B. 
cereus. This might be due to the presence of unknown active compounds in this extract, or to 
synergistic effects. The antibacterial activity of aronia substances was investigated by the disk 
diffusion method, and it was shown that they were not toxic to the species screened. This non-
toxic inhibition may confer a lower potential for resistance development compared to 
conventional antimicrobials.  
Paper IV.  Anthocyanins, proanthocyanidins and total phenolics in four cultivars of 
aronia: Antioxidant and enzyme inhibitory effects 
The aim of this paper was to compare four cultivars of Aronia (A. melanocarpa “Moskva”, 
“Hugin”, “Nero” and A. prunifolia) with respect to their phenolic composition, antioxidant 
and α-glucosidase inhibitory activity. The content of anthocyanins in the cultivars was 
determined by HPLC using a reverse phase chromolith column instead of other commonly 
used reverse phase columns. Due to its faster flow rate, separation was achieved much quicker. 
In this study, the separation was accomplished in less than four minutes, which is a 
considerable advantage compared to anthocyanin analysis performed previously. Variations in 
chemical composition between the cultivars were found, which could be explained at least 
partly by unequal growing conditions. Cyanidin 3-galactoside was the major anthocyanin in 
all cultivars, with the highest content in A. prunifolia (497 ± 20 mg/100 g FW). Also, A. 
prunifolia had the highest content of polyphenols (2996 ± 172 mg gallic acid equivalents/100 
g FW) and proanthocyanidins (4.79 g procyanidin B2 equivalents/100 g FW). For the food 
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industry and also for the herbal supplement industry, A. prunifolia should be the most 
interesting species as a high content of polyphenols is usually desirable. Anthocyanin 
fractions from all cultivars were shown to be potent α-glucosidase inhibitors. However, 
despite their variations in chemical composition only minor differences in biological activity 
between the cultivars were found.   
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4 Results and discussion 
4.1 Extraction and isolation procedures 
The aronia berries studied were obtained fresh and then kept at -20 ˚C until extraction, which 
was performed using different apparatus and procedures, as described in this chapter. 
For paper I and II, the freeze-dried and pulverized aronia berries from cultivar “Moskva” were 
extracted with DCM followed by EtOH in a Soxhlet apparatus. The plant residue was further 
extracted with 50% EtOH at 70 ˚C (paper I and II), followed by extraction with distilled H2O 
at 50 ˚C and 100 ˚C (paper II). This extraction procedure gives a rough separation of 
constituents with different polarity. The phenol–sulfuric acid method and 1H NMR analyses 
revealed that carbohydrates were present in the 50 ˚C and 100 ˚C H2O extracts, whereas 1H 
and 13C NMR analyses revealed the presence of proanthocyanidins in the 50% EtOH crude 
extract. In order to separate the tannins and pigments from other non-phenolic compounds, 
adsorption chromatography (Amberlite XAD-7HP) and adsorption and size exclusion 
chromatography (Sephadex LH-20) were performed with eluents of decreasing polarity 
(Figure 8) as described in paper I.  
 
Figure 8. Illustration of the extraction and fractionation procedure presented in paper I. 
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Due to lack of material, the extraction and fractionation had to be rerun for the studies 
presented in papers II and III. This time, column chromatography on Sephadex LH-20 without 
prior absorption on XAD-7HP was chosen (Figure 9) as described in paper II. For proper 
separation, a longer column (80 cm for paper II versus 30 cm for paper I) was used. Sephadex 
LH-20 columns can separate substances of different molecular weights; however, aromatic 
compounds such as proanthocyanidins can have a higher affinity to the column material than 
to the eluent leading to potential failure of size-based separation. Nevertheless, thiolysis of 
Sephadex fractions d and g indicated that the DP of proanthocyanidins found in subfractions 
Seph d-g increases with the elution volume. After a chromatographic run, collected fractions 
were combined as indicated by TLC. Spots were visualized by UV-irradiation (254 and 366 
nm) and by spraying with Ce(SO4)2 in aqueous sulfuric acid followed by heating to detect 
organic compounds.     
 
Figure 9. Illustration of the extraction and fractionation procedure presented in paper II. 
 
In parallel to this procedure, pure compounds were isolated by different extraction methods 
performed at room temperature since the Soxhlet system could cause thermal degradation of 
anthocyanins and procyanidins. Four anthocyanins (paper I) were isolated from aronia berries 
by extraction with 0.5% TFA in MeOH, removal of MeOH, and partitioning between ethyl 
acetate and water (Figure 10). The aqueous phase was purified by column chromatography 
(Amberlite XAD-7HP and Sephadex LH-20) and collected fractions were analyzed by HPLC. 
In addition, cyanidin aglycone was obtained by acidic hydrolysis of cyanidin 3-galactoside 
(paper III). The oligomeric procyanidins B2, B5, and C1 are present in black chokeberries 
(Kulling and Rawel, 2008); however, instead of using berries as the source, bark was chosen. 
Bark was indeed found to be a simpler source for isolation since the complexity with respect 
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to total phenolic structures was lower (e.g. no anthocyanins, paper I). Procyanidin dimers B2 
and B5 and trimer C1 (Figure 10) were extracted from aronia bark with 70% acetone, 
followed by defatting of the extract with DCM, partitioning against ethyl acetate and column 
chromatography (Sephadex LH-20). The obtained fractions were analyzed by TLC and HPLC.  
 
Figure 10. Compounds present in aronia berries. Cyanidin, anthocyanins and oligomeric procyanidins 
were isolated from aronia, whereas epicatechin and the phenolic acids were purchased from Sigma-
Aldrich. 
 
Isolated compounds were identified on the basis of their chromatographic and spectroscopic 
data such as TLC, HPLC and LC-MS. The optical rotation was also recorded as part of the 
characterization of the compounds. For stereoisomers in particular (e.g. chlorogenic and 
neochlorogenic acid), the optical activity is an important information to fully identify the 
compounds. Anthocyanins could not be measured due to their high absorbance at the sodium 
D wavelength. It has not been possible to find literature values for those, suggesting that 
others might have had a similar issue.  
After isolation, anthocyanins and procyanidins were kept in the dark, at low temperature and 
in a dry state. However, long time storage sometimes led to degradation, for example loss of 
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the sugar unit was observed for anthocyanins. Therefore, compounds were analyzed by HPLC 
prior to biological activity testing. The isolation, purification and structure determination of 
pure compounds are relatively time consuming processes. Hence, substances present in aronia 
that are commonly and easily available, such as epicatechin, chlorogenic and neochlorogenic 
acid, were purchased from Sigma-Aldrich.  
4.2 Chemical characterization (paper IV) 
The content of total phenolics and proanthocyanidins in 80% EtOH extracts of the four 
cultivars of aronia (Aronia melanocarpa "Moskva", "Hugin", "Nero" and Aronia prunifolia) 
were determined by using the Folin–Ciocalteu (F-C) method and the acid butanol assay, 
respectively. The F–C assay relies on the transfer of electrons in alkaline medium from 
phenolic compounds to phosphomolybdic/phosphotungstic acid complexes to form blue 
complexes which can be measured spectroscopically at 765 nm (Ainsworth and Gillespie, 
2007). Results are typically expressed as gallic acid equivalents. The chemistry is non-
specific and based on redox reactions, hence, other oxidation substrates in a given extract 
sample can interfere. Consequently, the method is not specifically detecting phenolic 
compounds since F-C reagent can also be reduced by other readily oxidized substances such 
as ascorbic acid. However, the F–C assay is simple, reproducible and has been widely used 
for approximating the total phenolic content in samples. The acid butanol assay is commonly 
used to determine condensed tannins (Hagerman, 2011; Amarowicz and Pegg, 2006). In this 
method, anthocyanidins are liberated from proanthocyanidins and they can be measured 
spectroscopically at 550 nm. Samples from aronia were colored (due to pigments) before the 
assay was employed, therefore absorbance values prior to hydrolysis were subtracted from 
absorbance values after hydrolysis in order to correct the contribution of natural occurring 
anthocyanins. 
HPLC is the method of choice for the accurate determination of both the composition and the 
concentration of anthocyanins in a given sample (Merken and Beecher, 2000). Anthocyanins 
are traditionally extracted and analyzed in acidic medium as the red flavylium cation is the 
most stable form (Crozier et al., 2009). Extracts of anthocyanins were therefore prepared from 
cultivars using 0.5% TFA in MeOH. HPLC equipped with a diode array detector using a 
reverse phase chromolith column was applied to identify and quantify the major pigments. In 
this study, the separation was accomplished much faster (less than four minutes) compared to 
anthocyanin analysis performed with other commonly used reverse phase columns due to a 
26 
 
faster flow rate in the chromolith column used. Our results with respect to total anthocyanin 
content were in accordance with previous investigations (Kulling and Rawel, 2008). Cyanidin 
3-galactoside was found to be the main anthocyanin in all cultivars, with the highest content 
in A. prunifolia (497 ± 20 mg/100 g FW). Also, A. prunifolia had the highest content of 
polyphenols (2996 ± 172 mg gallic acid equivalents/100 g FW) and proanthocyanidins (4.79 g 
procyanidin B2 equivalents/100 g FW). In this study, the phenolic composition did vary 
significantly among the various aronia cultivars. They were, however, neither grown under 
identical conditions, nor in the same locality, nor harvested on the same date. This may have 
had major impacts on the results. Nevertheless, Rop et al. (2010) showed that differences 
between cultivars of aronia were caused by both their geographic origin and genetic 
predispositions. The results of our study indicate that berries from A. prunifolia constitute the 
richest source of anthocyanins and proanthocyanidins among the cultivars investigated and 
might be the species of choice for the food and herbal supplement industry, as a high content 
of polyphenols is often desired.       
4.3 Biological activities 
4.3.1 Antioxidant activity 
In paper I and IV antioxidant activity was assessed using three different methods: scavenging 
of the DPPH radical, inhibition of 15-LO and inhibition of XO.   
In paper I, crude extracts of A. melanocarpa "Moskva" were inactive as antioxidants, except 
for the 50% EtOH extract, which showed moderate DPPH radical scavenging activity levels. 
In contrast, fractions (Amb-MeOH and Seph I-III) of the 50% EtOH extract and isolated 
compounds (anthocyanins and procyanidins) possessed high radical scavenging properties, 
strong inhibitory activity towards 15-LO and moderate inhibitory activity towards XO.   
Among the anthocyanins, cyanidin 3-arabinoside possessed the strongest radical scavenging 
and enzyme inhibitory activities and cyanidin 3-xyloside the weakest ones. These results may 
indicate that the antioxidant effects are influenced by the sugar units linked to the 
anthocyanidin. Also, trimeric procyanidin C1 showed higher activity levels in the biological 
assays compared to the dimeric procyanidins B2 and B5. Yokozawa et al. (1998) reported that 
the number and position of hydroxyl (OH) groups were important factors for the scavenging 
of free radicals by flavonoids and showed that an increase in molecular weight enhanced the 
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activity of tannins. Since the number of OH groups is correlated to the molecular size of 
procyanidins, our findings concur with the suggested theory.  
The antioxidant activities of both the 80% EtOH extracts and the acidic MeOH extracts of A. 
melanocarpa "Moskva", "Hugin", "Nero" and A. prunifolia were investigated (paper IV). 
Since there was a considerable variation in chemical composition between cultivars of aronia 
(see section 4.2), it was anticipated that these differences would lead to similarly varied 
results for antioxidant activity testing. However, only minor differences in antioxidant activity 
levels were found between the cultivars. In general, all extracts possessed moderate DPPH 
radical scavenging activity and relatively low 15-LO and XO inhibitory activity compared to 
the positive control quercetin (Table 1). Polyphenols are well known for their antioxidant 
activities, and as the extracts of A. prunifolia had the highest content of proanthocyanidins, 
anthocyanins and total polyphenols among the cultivars tested, it was expected that they 
would also have the highest antioxidant activity. The results showed however no correlation 
between the content of polyphenols in the extracts and their antioxidant activity level. 
Table 1. Antioxidant activity of four cultivars of aronia berries tested by DPPH radical scavenging, 
inhibition of 15-lipoxygenase and inhibition of xanthine oxidase. 
 DPPH 15-LO XO 
 
IC50 (μg/mL) % inh 83.3 μg/mL % inh 83.3 
μg/mL 
80% ethanol extract ’Moskva’ 35.7 ± 1.5 4.0 ± 2.7 25.5 ± 3.0 
80% ethanol extract ’Hugin’ 16.2 ± 0.4 10.9 ± 2.9 34.5 ± 2.0 
80% ethanol extract ’Nero’ 35.5 ± 1.4 8.9 ± 3.1 23.7 ± 4.1 
80% ethanol extract A. prunifolia 21.2 ± 0.7 5.7 ± 3.4 26.3 ± 2.7 
Acidified methanol extract 
‘Moskva’ 61.4 ± 1.6 8.5 ± 4.7 2.7 ± 1.6 
Acidified methanol extract ‘Hugin’ 39.7 ± 1.4 12.8 ± 5.7 14.7 ± 1.8 
Acidified methanol extract ’Nero’ 54.3 ± 1.6 17.4 ± 5.2 13.0 ± 3.8 
Acidified methanol extract A. 
prunifolia 
33.2 ± 1.3 14.7 ± 5.0 18.0 ± 5.5 
Quercetin (positive control) 3.3 ± 0.6 26.0 ± 2.0 1 0.6 ± 0.11 
1 presented as IC50 (concentration to give 50% inhibition) 
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The DPPH assay is technically simple, but presents some disadvantages (Huang et al., 2005). 
For example, the DPPH radical is a long-lived nitrogen radical, which has few similarities to 
the highly reactive and transient peroxyl radicals involved in lipid peroxidation. Many 
antioxidants that react quickly with peroxyl radicals may react slowly or may even be inert to 
DPPH. Also, it was reported that DPPH reacts reversibly with some polyphenols, resulting in 
altered radical-scavenging values (Denev et al., 2012; Huang et al., 2005). Generally the 
observed DPPH radical scavenging activity of aronia substances is promising but the 
limitations of the testing method should be taken into account for assessing the potential 
impact. 
Soybean lipoxygenase was used to measure the inhibition of 15-LO. Most of our knowledge 
on lipoxygenase structure and function originates from studies on soybean LO isoforms. In 
several aspects, such as reaction mechanism, kinetic parameters and iron content, the soybean 
15-LO constitutes a suitable model for mammalian lipoxygenases. Several investigations have 
found that there is a significant correlation between inhibitory activities towards the soybean 
and towards the mammalian 15-LO (Utenova et al., 2007 and references cited therein). 
However, there are other properties that differ between plant and mammalian lipoxygenases. 
Thus, it has been suggested that experimental data obtained with the soybean enzyme should 
be interpreted with care when conclusions to mammalian physiology are drawn (Kühn et al., 
2005). 
Allopurinol, a purine analogue, is a drug used primarily to treat gout and conditions associated 
with hyperuricemia (Pacher et al., 2006). Although allopurinol is a very efficient drug, it is a 
relatively weak XO inhibitor in in vitro assays. Therefore, one must be aware that in vitro 
inhibitory activities do not necessarily translate to in vivo inhibitory effects and vice versa. 
While it is often believed that polyphenols such as proanthocyanidins are unspecific enzyme 
inhibitors due to their unspecific protein-complex binding properties, previously reported 
results (Le et al., 2012) show that the inhibition of 15-LO and the inhibition of XO by a series 
of polyphenols are not significantly correlated, and that complex formation between 
proanthocyanidins and proteins is structure-dependent (Hatano et al., 1990; Santos-Buelga 
and Scalbert, 2000). 
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Despite some challenges and limitations associated with in vitro testing, the DPPH, 15-LO 
and XO assays cover different aspects of the antioxidant action and the results derived from 
these tests give a broader view on the antioxidant potential of aronia substances.  
The antioxidant activities of these substances in vivo would seem to be an important subject 
for further research. A key issue for in vivo activity is whether or not polyphenols reach their 
targets in the body in sufficient amounts to achieve the beneficial effects (Crozier et al., 2009). 
Anthocyanins and oligomeric/polymeric proanthocyanidins from aronia appear to have low 
bioavailability (see section 1.2.3). Their circulating metabolites may differ greatly in structure 
and potential function compared to the original compounds, which may therefore not be 
present in sufficient amount in the bloodstream to achieve the beneficial antioxidant effects 
there. However, the role of antioxidants in the GIT may also be of importance (Denev et al., 
2012). A usual diet contains various prooxidants, including metals such as iron, copper and 
heme, lipid hydroperoxides, aldehydes, and nitrite. In addition, elevated levels of lipid 
peroxides have been observed in the postprandial state. These prooxidants may induce 
oxidative stress in the gastrointestinal tract, which could for example be the source of stomach 
ulcers and induce stomach, colon, and rectal cancers. Due to the metal chelating ability, the 
radical scavenging activity and other antioxidant properties of polyphenols, it may be possible 
to suppress such oxidative stress and oxidative stress-mediated diseases in the GIT.  
Many of the colonic metabolites of the polyphenols from aronia might still have free OH 
groups and could maintain their antioxidant activity. When reaching the bloodstream, they 
may contribute to enhance plasma antioxidant capacity. Therefore, in addition to the original 
phenolic compounds, their metabolites should also be considered to understand the biological 
activities and antioxidant functions of polyphenols from aronia berries. 
4.3.2 α-Glucosidase inhibitory activity 
In paper I and IV, aronia substances were investigated for their abilities to inhibit the 
digestive enzyme α-glucosidase. The 50% EtOH crude extract, subfraction Amb-MeOH and 
compounds of A. melanocarpa "Moskva" were strong α-glucosidase inhibitors. All were more 
efficient than the positive control acarbose, the active compound in an anti-diabetic drug. In 
addition, anthocyanins were more active than the dimeric and trimeric procyanidins. Trimeric 
procyanidin C1 was also found to possess stronger inhibitory activity compared to the dimeric 
procyanidins B2 and B5. This concurs with previously reported results showing that the 
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activity increases with increasing molecular weight of oligomeric flavan-3-ols (Ma et al., 
2010).  The acidic MeOH extracts of the four aronia cultivars were all much more potent than 
their respective 80% EtOH extracts and the positive control, indicating that anthocyanins in 
these extracts might be responsible for the effects (paper IV). Matsui et al. (2001) examined 
the α-glucosidase inhibitory properties of natural anthocyanin extracts and also reported that 
these compounds showed strong in vitro activities. However, McDougall et al. (2005) showed 
that the extent of inhibition is related to the anthocyanin concentration. Based on our results 
from paper IV, we did not find such correlation between the total anthocyanin content in the 
extracts and extent of α-glucosidase inhibition. As for the antioxidant activity, only minor 
differences between the various cultivars were found for the α-glucosidase inhibitory activity.  
Since α-glucosidase is located in the brush border of the small intestine (Huang et al., 2010), 
the inhibition of this enzyme would take place in the GIT and therefore uptake of aronia 
compounds into the bloodstream is not necessary. Phenolic components in the GIT may 
influence digestive enzymes and our results indicate that aronia substances could interfere 
with glucose absorption from the small intestine. However, this is dependent on the stability 
of the polyphenols at intestinal pH. Investigation of aronia substances on α-amylase activity 
would be an interesting subject for future research, since this enzyme is also involved in the 
digestion of carbohydrates (Coniff and Krol, 1997).                  
4.3.3 CYP3A4 inhibitory activity 
Pharmacokinetic interactions often occur as a result of activity changes of drug-metabolizing 
proteins, especially cytochrome P450 isoenzymes. The inhibitory activities of aronia 
substances from A. melanocarpa, cultivar "Moskva", on CYP3A4 were investigated in paper 
II. Midazolam was used as the probe substrate, and recombinant insect cell microsomes 
expressing CYP3A4 were used as the enzyme source. In the initial screening study, a high 
concentration (226 μg/mL final concentration) of extracts, subfractions, and compounds was 
applied in order to compare their ability to inhibit CYP3A4. For the active substances (50 % 
EtOH crude extract, subfractions Seph d–g, cyanidin 3-arabinoside and procyanidin B5), 
measurements were done at lower concentrations and it was found that these samples inhibit 
CYP3A4 in a concentration-dependent manner. Interestingly, procyanidin B5 (IC50 value of 
44.6 ± 3.1 μg/mL for inhibition of 1´-OH MDZ) was a considerably stronger CYP3A4 
inhibitor in vitro than the isomeric procyanidin B2 (IC50 value > 226 μg/mL), and comparable 
to bergamottin, a known CYP3A4 inhibitor from grapefruit juice. Seph g (IC50 value of 
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5.4 μg/mL for inhibition of 1´-OH MDZ) was found to contain the highest concentration of 
proanthocyanidins with the highest DP and possessed the strongest CYP3A4 inhibitory 
activity, whereas subfractions Seph e (IC50 value of 17.9 μg/mL) and f (IC50 value of 
10.4 μg/mL) were found to contain less proanthocyanidins and also showed weaker CYP3A4 
inhibition. Based on these observations, it appears that the proanthocyanidins in these 
fractions are the constituents responsible for the observed in vitro inhibition. Also, the 
inhibitory activity of proanthocyanidin-containing fractions was correlated to the degree of 
polymerization. Among the anthocyanins, cyanidin 3-arabinoside showed stronger CYP3A4 
inhibition than cyanidin 3-galactoside and cyanidin 3-glucoside, thus suggesting that the 
ability to inhibit CYP3A4 in vitro is influenced by the sugar unit linked to the anthocyanidin. 
As pointed out in section 1.2.3, proanthocyanidins with high DP and anthocyanins appear to 
have low bioavailability, and metabolism is a factor strongly affecting their plasma 
concentrations. However, since CYP3A4 is the major CYP enzyme in the intestine, with 
highest content in the proximal small intestine and located in the apical enterocytes, 
substances that are able to penetrate the intestinal epithelial cell membrane have the potential 
to inhibit CYP3A4 even if they have low plasma concentrations and are extensively 
metabolized by conjugation reactions (Dresser and Bailey, 2003). Anthocyanins, dimers and 
trimers of flavan-3-ols have been reported to be able to cross the apical membrane of 
intestinal epithelial cells, but polymerization of proanthocyanidins greatly impairs their 
absorption (Denev et al., 2012; Hassimotto et al., 2008; Steinert et al., 2008; Wiczkowski et 
al., 2010). Consequently, the clinical relevance of the present in vitro observations needs to be 
further investigated. It would be interesting to measure the concentration of these compounds 
in products derived from the berries (e.g. juices, jams) and investigate if the inhibition of 
CYP3A4 can actually be experienced in vivo. 
4.3.4 Antimicrobial activity 
The formation of biofilms on medical devices such as catheters is a well known health hazard. 
Once a biofilm is established, it is difficult to eliminate because the bacteria are reinforced 
and protected by the matrix, making them more resistant to antibiotics (Estrela and Abraham, 
2010). In paper III, A. melanocarpa (cultivar "Moskva") extracts, subfractions and pure 
compounds were investigated for their abilities to prevent a biofilm formation and to inhibit 
bacterial growth of Escherichia coli and Bacillus cereus in vitro. The Gram-negative E. coli is 
the most common pathogen associated with urinary tract infections, and its biofilm formation 
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on urinary catheters is a known problem (Costerton et al., 1999). Bacillus cereus is a Gram-
positive, spore forming bacterium commonly identified as the source of food-borne diseases, 
but also as the cause for a number of systemic and local infections such as catheter-related 
bloodstream infections and pneumonia (Bottone, 2010). In general, the majority of the aronia 
samples displayed biofilm inhibition against the Gram-positive B. cereus at concentrations of 
1 mg/mL, but exhibited less activity against Gram-negative E. coli. The 50% EtOH crude 
extract was the most potent inhibitor of B. cereus biofilm formation, most likely due to the 
presence of unknown active compounds in this extract, or to synergistic effects. It was 
initially assumed that the observed anti-biofilm activity of samples was caused by bactericidal 
or bacteriostatic properties towards these bacteria. However, results derived from the disk 
diffusion method showed that growth of the species was not affected by aronia samples. This 
non-toxic inhibition may confer a lower potential for resistance development compared to 
conventional antimicrobials.  
It was planned to evaluate the activity of aronia samples against biofilm formation of two E. 
coli strains, E. coli K12 JM109 and uropathogenic E.coli. Uropathogenic E. coli made a very 
poor biofilm in this assay and good biofilm-forming conditions were not achieved for this 
bacterium. There are therefore no results related to this strain in this assay.   
An important aspect of research on mature biofilms is the testing of the response of bacteria 
within a biofilm to antibiotics compared to their response in a single-cell state. However, the 
purpose of this study was to investigate the potential effects of aronia on the inhibition of 
biofilm formation with planktonic bacteria as starting material. No antibiotics were added to 
the system as a positive control because planktonic bacteria would be sensitive to the 
antibiotics (as observed in the disk assay) and therefore would not form biofilms.  
A limitation of this study is that the measurements were made for only one endpoint (biomass) 
at a single test concentration, and therefore potency values could not established. Additional 
testing of other endpoints than biomass (e.g. resazurin staining for quantification of bacterial 
viability (Skogman et al., 2012)), dose-response relationships, and also potential effects of the 
compounds on mature biofilms would be interesting subjects for future research. 
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5 Conclusions 
Aronia berries already benefit from a positive image which is partly associated with the 
general acceptance that fruits and vegetables are an important part of the diet and a general 
trend towards a healthier lifestyle. In addition, in recent years, natural antioxidants have been 
praised for their beneficial effects on health.    
This study provides a better understanding of the potential health benefits of polyphenols 
from aronia berries. Several constituents from aronia showed activity as antioxidants, as α-
glucosidase inhibitors and displayed anti-biofilm activity against E. coli and B. cereus. It was 
however also found that some of these substances could inhibit the important drug-
metabolizing enzyme CYP3A4. This may potentially lead to undesirable pharmacokinetic 
interactions.  
In this study, the results were derived from in vitro experiments. Follow-up testing in vivo is 
necessary to validate the findings and a central subject for further research on the bioactivity 
of aronia. 
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Abstract: Extracts, subfractions, isolated anthocyanins and isolated procyanidins B2, B5 
and C1 from the berries and bark of Aronia melanocarpa were investigated for their 
antioxidant and enzyme inhibitory activities. Four different bioassays were used, namely 
scavenging of the diphenylpicrylhydrazyl (DPPH) radical, inhibition of 15-lipoxygenase 
(15-LO), inhibition of xanthine oxidase (XO) and inhibition of α-glucosidase. Among the 
anthocyanins, cyanidin 3-arabinoside possessed the strongest and cyanidin 3-xyloside the 
weakest radical scavenging and enzyme inhibitory activity. These effects seem to be 
influenced by the sugar units linked to the anthocyanidin. Subfractions enriched in 
procyanidins were found to be potent α-glucosidase inhibitors; they possessed high radical 
scavenging properties, strong inhibitory activity towards 15-LO and moderate inhibitory 
activity towards XO. Trimeric procyanidin C1 showed higher activity in the biological 
assays compared to the dimeric procyanidins B2 and B5. This study suggests that different 
polyphenolic compounds of A. melanocarpa can have beneficial effects in reducing blood 
glucose levels due to inhibition of α-glucosidase and may have a potential to alleviate 
oxidative stress. 
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1. Introduction 
Aronia, Aronia melanocarpa (Michx.) Elliott, syn. Photinia melanocarpa (Michx.) K. R. Robertson 
and J. B. Phipps, sometimes called black chokeberry, belongs to the Rosaceae family and is cultivated 
as a decorative shrub, as a source of berries for juices, wines and jams and as a rich source of natural 
food colorants [1,2]. In recent years, black chokeberries have gained popularity due to their high 
content of polyphenols with antioxidant activity [3]. In fact, they possess the highest antioxidant 
activity among berries and other fruits investigated so far as measured with the oxygen radical 
scavenging capacity (ORAC) assay [2,4]. The Aronia berries contain high levels of flavonoids, mostly 
anthocyanins and proanthocyanidins. The formation of free radicals is strongly associated with lipid 
peroxidation and has also been implicated in the development of a variety of diseases, including 
cellular aging, mutagenesis, inflammation, carcinogenesis, coronary heart disease and diabetes [5]. 
Accumulated evidence has suggested that diabetic patients are under oxidative stress, with an 
imbalance between the free radical generating and radical scavenging capacities [6–11].  
15-Lipoxygenase (15-LO) and xanthine oxidase (XO) are peroxidative and prooxidative enzymes, 
respectively, and sources of reactive oxygen species (ROS) in vascular cells [12,13]. An 
overproduction of ROS may be involved in endothelial dysfunction. Thus, substances that inhibit the 
production of ROS could have a positive effect on cardiovascular function. It has been suggested that 
A. melanocarpa fruit juice and its anthocyanins might be useful in the prevention and control of 
diabetes mellitus type II and diabetes associated complications [14,15]. α-Glucosidase, which is a 
membrane-bound enzyme located at the epithelium of the small intestine, plays a vital role in digestion 
of carbohydrates, as it catalyzes the cleavage of glucose from disaccharides and oligosaccharides. It 
might be possible to prevent the onset of diabetes by controlling postprandial hyperglycemia through 
the inhibition of α-glucosidase and α-amylase activities, resulting in a delay of carbohydrate digestion 
to absorbable monosaccharide [16]. Studies have revealed that anthocyanins potentially inhibit 
intestinal α-glucosidase, and Adisakwattana et al. [16] reported that cyanidin 3-rutinoside retards 
absorption of carbohydrates by that mechanism of action. To our knowledge, no systematic 
investigation on chokeberry anthocyanins and procyanidins as radical scavengers, lipoxygenase 
inhibitors, xanthine oxidase inhibitors and α-glucosidase inhibitors has been reported previously. 
The present paper reports in vitro antioxidant activity of extracts, subfractions, anthocyanins and 
procyanidins isolated from A. melanocarpa measured by scavenging of 1,1-diphenyl-2-picrylhydrazyl 
(DPPH) radical and inhibition of the enzymes 15-LO and XO. Furthermore, the polyphenol-rich 
extracts were tested for their ability to inhibit α-glucosidase. 
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2. Experimental Section 
2.1. Plant Material 
Aronia berries, A. melanocarpa (Michx.) Elliott var. Moscow, were harvested at Særheim, Klepp, 
Norway (58°47′N, 5°41′E) in August 2010. The berries were kept at −20 °C until extraction.  
A voucher specimen (MB201201) is deposited in the Pharmacognosy section, School of Pharmacy, 
University of Oslo, Norway. Bark, as a source of procyanidins, was sampled from the same plants. 
Branches with a diameter of 1–2 cm were chosen, and the bark was carefully removed. In total  
1500 g fresh weight (FW) was sampled, giving 732 g dry weight (DW) upon lyophilization. The plant 
material was cut in pieces and kept at −20 °C until extraction. 
2.2. Chemicals  
Diphenylpicrylhydrazyl (DPPH) radical, linoleic acid, 15-LO from soybeans, hypoxanthine, XO 
from bovine milk, α-glucosidase from baker’s yeast, 4-nitrophenyl α-D-glucopyranoside (PNP-G), 
quercetin, acarbose, sodium potassium phosphate, benzyl mercaptan, trifluoroacetic acid (TFA), 
dimethyl sulfoxide (DMSO), ethyl acetate (EtOAc), dichloromethane (DCM), acetone, ethanol (EtOH) 
and methanol (MeOH) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Procyanidin B2 
and B5 reference compounds were obtained from Plant Polyphenols LLC (Boyce, LA, USA). All other 
reagents were of the highest purity available. 
2.3. Extraction and Fractionation 
Aronia berries (5.5 kg FW) were freeze-dried, pulverized and extracted with DCM (5 L) followed 
by EtOH (4.5 L) in a Soxhlet apparatus. The plant residue was further extracted by stirring with  
3 × 3 L 50% EtOH at 70 °C for 2 h. All extracts were concentrated in vacuo, yielding 26 g, 250 g and 
80 g, respectively. The 50% EtOH extract (2.5 g) was fractionated on an Amberlite XAD-7HP  
(3 × 30 cm; Sigma-Aldrich, St. Louis, MO, USA) column by elution with 400 mL water followed by 
300 mL MeOH, 200 mL 0.1% TFA in MeOH and 200 mL acetone-water (70:30). The procedure was 
repeated until a total amount of 10 g had been applied on the column. The MeOH fraction  
(Amb-MeOH) was concentrated to dryness in vacuo, and a yield of 2 g was obtained. Of this, 920 mg 
was dissolved and further fractionated over Sephadex LH-20 (3 × 30 cm; GE Healthcare, Uppsala, 
Sweden) with MeOH-water (from 20:80 to 100:0) as eluent. This gave three subfractions, namely  
Seph I (418 mg; eluted with 20% MeOH), Seph II (44 mg; 40% MeOH) and Seph III (278 mg;  
100% MeOH). 
2.4. Isolation of Anthocyanins  
In parallel to the work described in section 2.3., Aronia berries (2 kg FW) were extracted by 
maceration with 2 × 6 L MeOH (0.5% TFA v/v) for 24 h at ambient temperature and most of the 
solvent evaporated in vacuo. The concentrated water-enriched extract (0.5 L) was partitioned against 
EtOAc (4 × 0.5 L). The organic phase was discarded, whereas the water-phase was concentrated and 
purified on a bed of Amberlite XAD-7HP (5 × 50 cm column) by use of water until the eluate had  
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pH 6 followed by elution with 1 L MeOH (0.5% TFA). The anthocyanin-enriched extract was then 
eluted through a Sephadex LH-20 column (5 × 100 cm) by use of a step gradient of 15% (3 L) and 
30% (4 L) MeOH (0.1% TFA v/v). Fractions of 200 mL were collected and analyzed by HPLC. Purity 
acceptance was defined as the analyte peak area representing >96% of total area as detected at 520 and 
280 nm. Overlapping fractions were combined and reapplied to the same column, and five column runs 
gave approximately 200 mg cyanidin 3-galactoside (1), 200 mg cyanidin 3-arabinoside (3) and  
20 mg cyanidin 3-xyloside (4). Only minute amounts of pure cyanidin 3-glucoside (2) were obtained.  
2.5. Isolation of Procyanidins  
Instead of using berries as a source of oligomeric procyanidins, bark was chosen, as this is a richer 
source and as this gave a simpler polyphenolic composition (e.g., no anthocyanins). A bark sample of 
466 g DW was extracted with 2 × 10 L 70% acetone at room temperature for 24 h. After concentration 
in vacuo, the 0.5 L extract was defatted with 2 × 0.5 L DCM. The organic phase, which contained  
6.4 g dry matter, was discarded. The sample was further partitioned against 3 × 0.5 L EtOAc, and the 
organic phase was concentrated in vacuo, followed by lyophilization. The EtOAc part yielded  
7.8 g DW. Of this, 2 g was applied to a 5 × 100 cm column of Sephadex LH-20, and separation was 
achieved by use of a step gradient of 50% (2 L), 80% (3 L) and 100% (10 L) MeOH. Fractions of 1 L 
were collected and analyzed by thin layer chromatography (TLC) and HPLC. About 200 mg 
procyanidin B2 (5), 20 mg B5 (6) and 50 mg of C1 (7) were obtained. Purity acceptance was defined 
as the analyte peak area comprising >96% of total chromatographic area at 280 nm and at fluorescence 
detection (see section 2.6.). 
2.6. Analysis  
2.6.1. TLC 
TLC analysis of procyanidins was performed with silica gel on polyethylene terephthalate (PET)-foils 
(Sigma-Aldrich, St. Louis, MO, USA) in the mobile phase system EtOAc-HCOOH-HOAc-H2O 
(75:2:3:20 v/v), upper layer. Mobile-phase distance was 10 cm. Spraying with vanillic acid-HCl-MeOH 
(1:4:100, w/v/v), followed by heating with a hair dryer, was used for spot detection. 
2.6.2. HPLC 
An Agilent 1100-system, Agilent Technologies (Santa Clara, CA, USA), was used for the purity 
check of the individual anthocyanins, and they were identified by comparison with in-house reference 
compounds [17]. Separation took place over an Eclipse XDB-C8 (4.6 × 150 mm, 5 μm) column 
(Agilent Technologies, Santa Clara, CA, USA) by use of a binary solvent system consisting of (A) 
HCOOH-H2O (1:9 v/v) and (B) HCOOH-MeOH-H2O (10:50:40, v/v). The gradient (B in A) was 
isocratic, with 0% B for 2 min, linear from 0% to 70% in 18 min, from 70% to 100% for the next 2 
min, from 100% to 0% in 2 min, followed by recondition of the column for 2 min. All HPLC samples 
were filtered through a 13 mm syringe filter (Nylon 0.45 μm, VWR International, Radnor, PA, USA) 
prior to injection. The flow rate was 0.8 mL/min, 10 μL samples were injected on the column and 
separation took place at 30 °C. Chromatograms were obtained at 280 and 520 nm. 
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HPLC analyses of procyanidins were performed on the same instrument and column with the 
solvent system (A) 0.05% TFA and (B) 0.05% TFA in MeCN. The gradient (B in A) was 5% (10 min), 
from 5% to 15% (10 min), from 15% to 20% (10 min), from 20% to 100% (6 min), from 100% to 5% 
(4 min) and finally recondition of the column for 2 min. The flow rate was 0.5 mL/min, column 
temperature 30 °C, and aliquots of 10 μL were injected. Fluorescence detection was achieved with 
excitation at 276 nm and emission at 316 nm (HP 1046A detector, Hewlett-Packard, Palo Alto, CA, 
USA), whereas UV-absorbance was detected at 280 nm.  
2.6.3. UV Measurements 
For UV measurements used in bioassay, a Biochrom Libra S32 PC (Biochrom Ltd, Cambridge, 
UK) was employed.  
2.6.4. Thiolysis 
About 10 mg crude extract was dissolved in 5% benzyl mercaptan in MeOH containing 1.1% HCl 
(v/v) and kept at 50 °C for 30 min. Procyanidin B1 and B2 were used as standards, with terminal units 
catechin and epicatechin, respectively. The products following the thiolysis reactions were analyzed by 
the method described for procyanidins on HPLC. 
2.6.5. Mass Spectrometry 
Crude extracts of berries (MeOH-extract) and bark (70% acetone), together with the isolated 
procyanidins, were further characterized by liquid chromatography coupled with mass spectrometry 
(LC-MS) using a nanoAcquity ultra performance liquid chromatography (UPLC) (Waters, Milford, 
MA, USA) coupled with a quadrupole time-of-flight (QTOF) micro hybrid mass spectrometer 
(Waters) equipped with nanoLockspray mass calibration. Reversed phase separations were achieved 
on a 600 mm long and 0.05 mm ID in-house prepared porous polymer monolithic column. The mobile 
phase consisted of (A) 0.1% formic acid and 0.05% ammonium hydroxide in water mixed with  
(B) 0.1% formic acid in acetonitrile. Injection of 2 μL sample diluted in water was done with a high 
flow rate (3 μL/min) for 5 min on a short trap column (50 mm) of a similar type as the analytical 
column, using a mobile phase composition of 1% B. A linear gradient from 0 to 10 min was performed 
by varying B from 2% to 10% at an elevated flow rate of 400 nL/min, in order to compensate for the 
large dwell volume. Then, the flow rate was reduced to 200 nL/min and the compounds eluted with  
a gradient reaching 30% of B at 30 min and 80% of B at 40 min. Electrospray ionization in the positive 
mode (ESI+) was used with a capillary voltage at 3 kV and a cone voltage at 35 V. Mass spectra were 
collected in the m/z range of 200–2000 with 1 s scantime. Instrument control, data acquisition and data 
processing were done by using MassLynx 4.1 software (Waters, Milford, MA, USA). 
2.6.6. NMR 
1H and 13C nuclear magnetic resonance (NMR) spectroscopy of extract and fractions were 
conducted on Varian Gemini 200 (Varian, Palo Alto, CA, USA), Bruker DPX 300 or Bruker AVII 400 
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(Bruker, Rheinstetten, Germany) instruments and performed in CDCl3 or CD3OD with 
tetramethylsilane (TMS) as an internal standard.  
2.7. DPPH Radical Scavenging  
Scavenging activity towards the DPPH radical was carried out as previously described [18].  
Briefly, to 2.95 mL of a methanolic solution of DPPH (A517 1.0), 50 μL of the test compound 
(dissolved in DMSO or MeOH) was added. The mixture was stirred, and the decrease in UV 
absorbance at 517 nm was measured over a period of 5 min. Percent radical scavenging was calculated 
as 100 × (Astart − Aend)/(Astart), where Astart is the absorbance before addition of the test compound and 
Aend is the absorbance value after 5 min of reaction time. Values were corrected for absorbance of the 
test substances. Quercetin was used as a positive control. 
2.8. Inhibition of 15-Lipoxygenase (15-LO)  
Soybean lipoxygenase was used to measure inhibition of 15-LO. To a solution of linoleic acid  
(134 μM) in borate buffer (0.2 M, pH 9.00, 2.90 mL) was added 50 μL of test substance dissolved in 
DMSO or MeOH or (for blanks) DMSO or MeOH alone. A solution of 15-LO in 50 μL borate buffer 
(10,000 U/mL) was added, and the increase in absorbance at 234 nm from 30 to 90 s after addition  
was measured. Percent enzyme inhibition was calculated as 100 × [(∆A1 − ∆A2)/∆A1], where ∆A1 and 
∆A2 are values for increase in A234 for sample without test substance and with test substance,  
respectively [18]. Quercetin was used as a positive control. 
2.9. Inhibition of Xanthine Oxidase (XO) 
The XO inhibitory activity with hypoxanthine as the substrate was measured spectrophotometrically 
based on the procedure of Noro et al. [19], with some modifications. The assay mixture consisting of 
50 μL of test compound (dissolved in DMSO or MeOH) or (for blanks) DMSO or MeOH alone,  
1.85 mL of 50 mM sodium-potassium phosphate buffer (pH = 7.5) and 100 μL of enzyme solution  
(1.8 U/mL in 50 mM sodium-potassium phosphate buffer, pH = 7.5) was prepared immediately before 
use. Substrate solution (1.0 mL, 20 μg/mL hypoxanthine in distilled water) was added. The mixture 
was stirred, and the increase in absorbance at 290 nm was measured over a period of 5 min. Percent 
enzyme inhibition was calculated as 100 × [(∆A1 − ∆A2)/∆A1], where ∆A1 and ∆A2 are values for the 
increase in A290 for the sample without test substance and with test substance, respectively. Quercetin 
was used as a positive control. 
2.10. α-Glucosidase Inhibitory Activity  
The α-glucosidase inhibitory activity was determined by a slight modification of the procedure 
reported by Matsui et al. [20]. The enzyme solution was set at 800 mU/mL of α-glucosidase in  
a 50 mM phosphate buffer (pH = 7.0) containing 100 mM sodium chloride. For each assay, 20 μL of 
the test solution in DMSO or MeOH and 80 μL of the enzyme solution were preincubated at 37 °C for 
5 min. The reaction was started by adding 1.9 mL of substrate solution (0.7 mM PNP-G in the buffer), 
and the solution was then incubated at 37 °C for 15 min. After the reaction had been stopped by adding 
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2.0 mL of a 0.5 M Tris solution, the absorbance of PNP released from PNP-G at 400 nm was 
measured. Percent enzyme inhibition was calculated as 100 × (AB − AS)/(AB), where AB and AS
represent the absorbance of the blank and sample, respectively. Acarbose was used as a positive control. 
2.11. Statistics 
Samples for DPPH, 15-LO, XO and α-glucosidase assays were analyzed in triplicate and results are 
given as averages ± SD. Student’s t test was used for statistical evaluation and p < 0.05 was considered 
statistically significant. 
3. Results and Discussion 
3.1. Extraction and Chemical Characterization  
In chokeberry fruits, anthocyanins constitute the second largest group of phenolic compounds [1]. 
The anthocyanins in A. melanocarpa are mainly a mixture of four cyanidin glycosides:  
3-galactoside, 3-glucoside, 3-arabinoside and 3-xyloside, of which cyanidin 3-galactoside is the main 
one (Figure 1) [17]. In order to isolate the major anthocyanins from Aronia berries, extraction with 
MeOH containing TFA was performed, since direct alcoholic extractions provide very poor yield, not 
keeping anthocyanins in the stable flavylium cationic form. The anthocyanins (1–4) were isolated as 
pure compounds, and their structures are shown in Figure 2. Their chromatographic and spectral 
characteristics were in agreement with previous observations [17]. Aronia berries were also extracted 
as shown in Figure 3. 
Figure 1. High-performance liquid chromatography (HPLC) chromatogram of the isolated 
anthocyanins: cyanidin 3-galactoside (1), cyanidin 3-glucoside (2), cyanidin 3-arabinoside (3) 
and cyanidin 3-xyloside (4). 
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Figure 2. Chemical structures of compounds isolated from berries and bark of Aronia. 
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Figure 3. Procedure for extraction and fractionation from berries of Aronia. Anthocyanins 
(section 2.4.) and procyanidins (section 2.5.) were extracted by different procedures. 
 
1H NMR and 13C NMR analysis revealed that proanthocyanidins were present in the 50% EtOH 
extract (70 °C). Subfractions of the extract were further shown to consist mainly of proanthocyanidins 
with epicatechin stereochemistry (1H NMR: B-ring protons: ca. 6.8 ppm, A-ring protons: ca. 6.0 ppm [21];
13C NMR: C-2 at ca. 77 ppm, no signals at 80–82 ppm [22]). However, fraction Seph II (eluted with 
40% MeOH) did not contain proanthocyanidins. 
In parallel to this procedure, dimeric (5 and 6) and trimeric (7) procyanidins (Figure 2) were 
isolated from Aronia bark. The bark was found to be a simpler source for isolation of procyanidins 
compared to berries, as the complexity with respect to total phenolic structures was lower  
(e.g., no anthocyanins). The concentration of procyanidins was higher in Aronia bark, as well. It has 
previously been shown that procyanidins B2, B5 and C1 are present both in bark and berries of the 
Aronia plant [2]. The isolated compounds were identified by co-chromatography against authentic 
substances (B2 and B5) and by mass spectrometry (Figure 4, Table 1). Thiolysis of crude extracts 
revealed that epicatechin was the major monomeric unit of the procyanidins, both as the starter and 
extender unit. Only minor amounts of catechin were detected. This might be due to epimerization  
of epicatechin. 
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Figure 4. HPLC chromatogram of a bark extract of Aronia melanocarpa showing 
procyanidins B2 (5), B5 (6) and C1 (7). 
 
Table 1. Chromatographic and spectral characterization of anthocyanins and procyanidins 
from Aronia melanocarpa. 
 Compounds TLC HPLC LCMS [M + H]+ Fragments 
(amu)   rRF tR (min) tR (min) 
1 cyanidin 3-galactoside 12.9 22.0 449.104 287.044
2 cyanidin 3-glucoside 13.9 22.2 449.102 287.044
3 cyanidin 3-arabinoside 15.0 22.7 419.084 287.039
4 cyanidin 3-xyloside 17.8 24.3 419.085 287.040
epicatechin 79 25.1 28.5 291.078
5 epi-(4βo8)-epi (B2) 58 23.4 29.9 579.157 291.078
6 epi-(4βo6)-epi (B5) 67 32.5 35.6 579.168 291.084
7 epi-(4βo8)-epi-(4βo8)-epi (C1) 51 26.7 32.7 867.216 579.143, 291.080
It has previously been reported that polymeric procyanidins, composed predominantly of 
(−)-epicatechin units, are the major class of polyphenolic compounds in chokeberry [1,3]. The degree 
of polymerization of procyanidins varies from 2 to 23 units in the fruits, with clear domination of 
>decamers fraction and with flavan-3-ol subunits connected mainly with C4–C6 and C4–C8 bonds 
(B-type bonds) [1]. Free epicatechin is also present in black chokeberries, although its concentration is 
significantly lower in comparison with polymeric procyanidins. Previous investigations have reported 
anthocyanin concentrations of 0.6%–2% (DW) and procyanidin concentrations of 4%–5% (DW) in 
Aronia berries [2]. 
3.2. Biochemical Activities  
The activity of crude extracts, subfractions and isolated compounds as DPPH scavengers, 15-LO 
and α-glucosidase inhibitors is shown in Table 2. The 50% EtOH crude extract showed high radical 
scavenging activity, and the effect was strengthened in the subfractions enriched in procyanidins 
(Amb-MeOH, Seph I and Seph III fraction). Trimeric procyanidin (compound 7) showed higher 
radical scavenging activity than the dimeric procyanidins (compound 5 and 6). The radical scavenging 
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ability of compound 5 and 7 is in good accordance with the literature [23,24]. Compound 6, however, 
seems to be previously unreported as a DPPH scavenger. Anthocyanins also possessed high radical 
scavenging capacity. IC50 values could not be established for compounds 1–4, since an increase in 
sample concentration resulted in a strongly colored mixture that influenced the UV-absorbance. For 
this reason, percent scavenging at a sample concentration of 10.4 μg/mL was measured. Compound 1–3 
were found to have the strongest DPPH scavenging capacity among the anthocyanins. The activity of 
compound 4 differed from the activity of the other anthocyanins, having the weakest DPPH radical 
scavenging capacity. Hence, sugar units linked to the anthocyanidin might have an influence on the 
biological effect. The radical scavenging activity of the anthocyanins is in fair accordance with 
previous investigations, although compound 3 has been reported to be slightly less active than 2 [25]. 
Table 2. Scavenging of the diphenylpicrylhydrazyl (DPPH) radical, 15-LO and  
α-glucosidase inhibitory activity of Aronia extracts, fractions and compounds. 
Material 
DPPH 
IC50 a (μg/mL) #/ 
% scavenging at 10.4 μg/mL ^ 
α-Glucosidase 
IC50 a (μg/mL) 
15-Lipoxygenase 
IC50 a (μg/mL) 
DCM >167 # Inactive >83 
EtOH >167 # Inactive >83 
50% EtOH 25.0 ± 5.0 # 3.5 ± 0.1 >83 
Amb-MeOH 3.8 ± 0.2 # 0.55 ± 0.01 56.7 ± 0.7 
Seph I 3.1 ± 0.5 # nt b 30.3 ± 0.7 
Seph II 12.0 ± 2.8 # nt b 91.0 ± 4.8 
Seph III 4.0 ± 0.5 # nt b 33.0 ± 2.0 
Compound 1 39.0 ± 2.9 ^ 1.54 ± 0.1 71.5 ± 1.8 
Compound 2 37.0 ± 0.9 ^ 0.87 ± 0.2 73.3 ± 2.1 
Compound 3 40.0 ± 0.4 ^ 0.37 ± 0.08 58.7 ± 2.5 
Compound 4 25.0 ± 5.0 ^ 5.5 ± 1.6 >83 
Compound 5 4.7 ± 0.3 # 4.7 ± 0.2 65.1 ± 2.6 
Compound 6 5.2 ± 0.1 # 5.5 ± 0.1 72.3 ± 5.7 
Compound 7 3.2 ± 0.1 # 3.8 ± 0.2 57.6 ± 2.0 
Quercetin (control) 3.0 ± 0.2 # nt b 26.0 ± 2.0 
Acarbose (control) nt b 130.0 ± 20.0 nt b 
a IC50: Concentration to give 50% scavenging or inhibition; b nt: Not tested; DCM: dichloromethane. 
The 50% EtOH crude extract, the Amb-MeOH fraction and compound 1–7 showed high activity in 
the α-glucosidase assay compared to the positive control acarbose, an anti-diabetic drug. In addition, 
the purified anthocyanins were more active than the isolated dimeric and trimeric procyanidins 
(compound 5–7). It is known that some anthocyanin extracts from plants exert a potent in vitro  
α-glucosidase inhibitory effect [26]. Also, McDougall et al. [27] found that the extent of inhibition of 
α-glucosidase is related to the anthocyanin content in different soft fruits. Among the anthocyanins, 
compounds 2 and 3 showed the highest activity and compound 4 the lowest. The activity of substance 
1 is consistent with the literature [28]. To our knowledge, α-glucosidase inhibitory activity of 
substances 2–7 has not been reported previously. Ma et al. [29] showed that the α-glucosidase 
inhibitory activity of flavan-3-ol monomer and oligomers increased as the molecular weight increased, 
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with a significant difference in potency between the strongest ones (pentamers) and the weakest one 
(monomer). The Amb-MeOH fraction appeared to contain polymeric procyanidins, and this could 
explain its strong effect towards α-glucosidase. Trimeric procyanidin (compound 7) possessed stronger 
α-glucosidase inhibitory activity compared to the dimeric procyanidins (compound 5 and 6). It 
appeared that the activity increased with increasing molecular weight, which is in good accordance 
with previously reported results [29]. For the anthocyanins, we found a highly significant correlation 
between α-glucosidase inhibition and DPPH radical scavenging activity (p < 0.005, R2 = 0.997). This 
is in good accordance with the literature [6]. For the crude extracts, the Amb-MeOH fraction and the 
procyanidins, the correlation was not significant. The Sephadex LH-20 fractions (Seph I–III) could not 
be tested for α-glucosidase inhibitory activity due to lack of material. 
The Amb-MeOH fraction showed high inhibitory activity toward 15-LO, and the effect was 
strengthened in the subfractions enriched in procyanidins (Seph I and Seph III fraction). Differences in 
activity between isolated anthocyanins and procyanidins were relatively small. Both groups of 
compounds possessed high 15-LO inhibitory ability, with compound 3 and 7 being the most active 
ones. The 15-LO inhibition of 1, 2, 3 and 7 is in accordance with previous investigations [23,30]. 
Substances 4, 5 and 6, however, seem to be previously unreported as 15-LO inhibitors.  
The activity of crude extracts, subfractions and isolated compounds as XO inhibitors is presented  
in Table 3. 
Table 3. Xanthine oxidase inhibitory activity of extracts, fractions and compounds from 
Aronia berries. 
Material % inhibition at a concentration of 42 μg/mL 
DCM Inactive 
EtOH Inactive 
50% EtOH Inactive 
Amb-MeOH 26.3 ± 3.4 
Seph I 32.2 ± 7.8 
Seph II 19.9 ± 7.6 
Seph III 46.5 ± 5.9 
Compound 5 12.7 ± 2.8 
Compound 6 6.6 ± 0.7 
Compound 7 15.5 ± 1.5 
 % inhibition at a concentration of 17 μg/mL 
Compound 1 11.9 ± 4.4 
Compound 2 20.9 ± 3.4 
Compound 3 39.1 ± 2.1 
Compound 4 11.4 ± 2.8 
The Amb-MeOH fraction possessed modest activity in the XO assay, and the effect was again 
strengthened in the subfractions enriched in procyanidins (Seph I and Seph III fraction). Due to 
absorbance above the upper detection limit of the spectrometer (sample concentrations >42 μg/mL for 
crude extracts, subfractions and procyanidins and sample concentrations >17 μg/mL for anthocyanins), 
higher concentrations of extracts and compounds could not be tested. Compound 7 was the strongest 
inhibitor among the isolated procyanidins, and compound 3 was the strongest among the anthocyanins. 
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However, all were less efficient than the positive control quercetin (IC50 0.6 ± 0.1 μg/mL). To our 
knowledge, inhibition of XO of Aronia berry extracts and substances 1, 3, 4 and 6 have not been 
reported previously. The 50% EtOH crude extract showed no inhibitory activity toward XO. 
Both the DCM and the EtOH crude extract were inactive as DPPH radical scavengers, 15-LO, XO 
and α-glucosidase inhibitors. Among the isolated anthocyanins, compound 3 possessed the strongest 
and compound 4 the weakest radical scavenging and enzyme inhibitory activity. These effects seem to 
be influenced by the sugar units linked to the anthocyanidin. Trimeric procyanidin (compound 7) 
showed higher activity in the biological assays compared to the dimeric procyanidins (compounds 5 
and 6), and it appeared that the activity increased with increasing molecular weight. In addition, there 
was a difference in activity between the two dimeric procyanidins, with compound 5 being the most 
active one. Reactive oxygen species can be generated by the prooxidative enzyme, XO, and the 
peroxidative enzyme, 15-LO, in vascular cells [31]. Components isolated from Aronia berries 
demonstrated inhibitory activity towards 15-LO and XO and may have a potential to alleviate 
oxidative stress. Until recently, anthocyanins were believed to have a very low bioavailability, but it 
has been demonstrated that the bioavailability of anthocyanins was underestimated [32,33]. In 
addition, anthocyanins are some of the few polyphenols that can be detected unmetabolized (e.g., as 
glycosides) in plasma [32]. It has to be taken into consideration that the bioavailability of flavanols 
varies depending on the degree of polymerization. Low molecular weight oligomeric procyanidins  
(DP ≤ 3) are absorbed intact in the gastrointestinal tract, but polymerization greatly impairs intestinal 
absorption [32–34]. In order to act as 15-LO and XO inhibitors in vivo, constituents have to be 
absorbed from the gastrointestinal tract. In view of the known bioavailability of tested compounds, 
Aronia products and extracts containing anthocyanins and oligomeric procyanidins (DP ≤ 3) may have 
biologically relevant 15-LO and XO effects. Inhibition of α-glucosidase delays carbohydrate digestion 
and the absorption of monosaccharides from the intestine [16]. Fractions enriched in procyanidins, the 
purified procyanidins and anthocyanins from A. melanocarpa berries were potent α-glucosidase 
inhibitors, suggesting that they may have beneficial effects in reducing blood glucose level. In order to 
act as α-glucosidase inhibitors in vivo, compounds do not have to be absorbed from the gastrointestinal 
tract, since it is a membrane-bound enzyme located at the epithelium of the small intestine [20]. 
Therefore, anthocyanins and procyanidins with even a high degree of polymerization may exert local 
effects in the gastrointestinal tract as α-glucosidase inhibitors. 
4. Conclusions  
We have shown that some extracts, fractions and constituents from A. melanocarpa possess activity 
of potential health benefits as radical scavengers, 15-LO inhibitors, XO inhibitors and α-glucosidase 
inhibitors in vitro. The difference in activity between the trimeric procyanidin C1 and the dimeric 
procyanidins B2 and B5 has, to our knowledge, not been reported previously. Also, it was found that 
the activity seems to be influenced by the sugar units linked to the anthocyanidin. No systematic 
investigations of A. melanocarpa extracts and fractions as radical scavengers, 15-LO inhibitors, XO 
inhibitors and α-glucosidase inhibitors has been reported previously. The activities of these extracts, 
fractions and compounds in vivo would seem to be an important subject for further research. The 
presence of biologically active compounds in Aronia berries increases the nutritional value of this 
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plant, as a rich source of radical scavengers and inhibitors of peroxidative and prooxidative enzymes 
(15-LO, XO) and of α-glucosidase, an enzyme which may be involved in diabetes. This would appear 
to be of interest to the food industry. 
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Abstract: Many bacteria growing on surfaces form biofilms. Adaptive and genetic changes 
of the microorganisms in this structure make them resistant to antimicrobial agents. 
Biofilm-forming organisms on medical devices can pose serious threats to human health. 
Thus, there is a need for novel prevention and treatment strategies. This study aimed to 
evaluate the ability of Aronia melanocarpa extracts, subfractions and compounds to prevent 
biofilm formation and to inhibit bacterial growth of Escherichia coli and Bacillus cereus  
in vitro. It was found that several aronia substances possessed anti-biofilm activity, 
however, they were not toxic to the species screened. This non-toxic inhibition may confer a 
lower potential for resistance development compared to conventional antimicrobials. 
Keywords: Aronia melanocarpa; biofilm formation; Escherichia coli; Bacillus cereus; 
flavonoids 
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1. Introduction 
Bacterial biofilms are sessile communities embedded within a self-produced matrix of extracellular 
polymeric substance (EPS) that are ubiquitous in natural, medical, and engineering environments [1,2]. 
Biofilms formed by pathogenic Gram-negative Escherichia coli strains can pose serious problems to 
human health, such as prostatitis, biliary tract infections, and urinary catheter cystitis [3]. Deleterious 
biofilms are also problematic in industry since they can cause fouling and corrosion in systems such as 
heat exchangers, oil pipelines, and water systems [1]. Bacillus cereus is a Gram-positive, spore 
forming bacterium closely related to the human and animal pathogen Bacillus anthracis, the cause of 
anthrax. B. cereus is frequently identified as the causative agent of food-borne diseases. As such, the 
interest in this bacterium is growing. This ubiquitous organism can easily contaminate food production 
or processing systems and forms biofilms that are highly resistant to cleaning procedures [4,5].  
In addition to food poisoning, B. cereus strains have the potential to cause a number of systemic and 
local infections in both immunologically compromised and, although less frequent, immunocompetent 
individuals. Certain groups of individuals are more commonly infected, including neonates, 
intravenous drug abusers, and patients with traumatic or surgical wounds, or with indwelling catheters. 
The disease spectrum is wide, including (but not limited to) catheter-related bloodstream infections, 
central nervous system (CNS) disease (meningitis and brain abscesses), endophthalmitis, and 
pneumonia [6]. 
Bacteria in a biofilm are often responsible for reoccuring symptoms and medical treatment  
failure [7,8]. Biofilm infections are difficult to eradicate because the genetic program (global gene 
expression pattern) of bacteria within such a structure is fundamentally changed, resulting in increased 
protection against e.g., macrophages and antibiotics, compared to planktonic (free living) cells [9]. 
Thus, the eradication of E. coli biofilms required 220 times higher antibiotic concentrations than for 
the same strain in serum. Also, the fact that many cells in a biofilm live for extended periods without 
going through cell division, contributes to resistance toward antibiotics, which are primarily effective 
on dividing cells [8]. In addition, some protection may be conferred by the physical barrier provided 
by the presence of the EPS that covers the biofilm and may prevent sufficient antibiotic exposure to 
kill the cells. Hence, novel antagonists with the potential to remove and/or prevent the formation of 
biofilms are needed. Agents which do not directly inhibit bacterial growth may confer a lower 
selection pressure for resistance development [1,10]. Recently, there has been a tremendous increase  
in biofilm research. An important focus of this research has been the development of alternative 
approaches, either to avoid the use of antimicrobials altogether, or to combine alternative treatments 
with more traditional antimicrobial drugs with the potential to totally eliminate biofilm formation on 
e.g., indwelling devices [11]. 
The aronia plant (Aronia melanocarpa (Michx.) Elliott var. Moscow (Rosaceae)) has gained 
popularity in recent years due to its berries with a high content of polyphenols with antioxidant  
activity [12,13]. Aronia products are used as nutritional supplements, and the berries are an important 
source for juices, wines, and jams, and constitute a rich source of natural food colorants [12,14]. 
Aronia berries contain high levels of flavonoids, mostly proanthocyanidins and anthocyanins. Also, 
chlorogenic and neochlorogenic acids are known constituents [15]. 
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Here we present the first study investigating the effects of aronia constituents on biofilm formation, 
complementing earlier studies investigating the antimicrobial activity of aronia berry extracts against 
Staphylococcus aureus, Escherichia coli, and type A influenza virus [16]. The aim of the present  
study was to screen extracts, subfractions and compounds from A. melanocarpa for their abilities to 
inhibit biofilm formation of E. coli and B. cereus in vitro. Effects on preformed biofilms were not 
investigated. This study represents a continuation of our research on the bioactivity of aronia [17,18]. 
2. Results and Discussion 
Aronia berries were extracted with dichloromethane (DCM), 96% EtOH, 50% EtOH, and H2O as 
previously described [17]. 1H-NMR and 13C-NMR analyses revealed that proanthocyanidins were 
present in the 50% EtOH extract, which was further fractionated on a Sephadex LH-20 column to yield 
subfractions Seph a–g. Seph d and Seph g were chosen for further studies since their proanthocyanidin 
compositions had been well characterized. Seph d contained only trace amounts of proanthocyanidins 
with an average degree of polymerization (DP) of seven, whereas the majority of proanthocyanidins, 
with an average DP of 34, was found in Seph g. The proanthocyanidins in the subfractions were found 
to contain epicatechin as the monomeric unit. Also, compounds 1–11, all well known constituents in 
aronia berries [14,15], were included in this study (Figure 1). Isolated compounds were identified on the 
basis of their chromatographic and spectroscopic data (TLC, HPLC, LC-MS) and optical rotations [17]. 
Figure 1. Chemical structures of compounds 1–11. 
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Due to the growing interest in antimicrobial agents that can prevent or treat infections caused by 
biofilm-forming bacteria, aronia extracts, subfractions and compounds were tested for their ability to 
prevent biofilm production of two clinically relevant bacterial pathogens, B. cereus and E. coli, at 
sample concentrations of 1 mg/mL (125 μg per well) in a microtiter plate assay that constitutes a  
long-established method of measuring biofilm formation in vitro [19,20]. Maximum biofilm mass 
employing this assay was observed after 48 h of incubation for B. cereus [21] and after 24 h for E. coli 
(data not shown). These incubation times were therefore applied to investigate the abilities of aronia 
samples to inhibit biofilm formation. Polyvinyl chloride (PVC) microtitre plates were chosen in this 
assay since this material is often used in the manufacturing of medical devices, such as catheters [22]. 
The majority of aronia samples displayed biofilm inhibition against the Gram-positive B. cereus strain 
407 (Figure 2), but exhibited less activity against Gram-negative E. coli JM109 (Figure 3). However, 
two samples (DCM extract and compound 6) that showed no anti-biofilm activity against B. cereus, 
were effective against E. coli. In fact, compound 6 was the most active against biofilm-producing  
E. coli, whereas the 50% EtOH extract displayed the most potent inhibition of biofilm formation 
against B. cereus. 
Figure 2. Biofilm formation of B. cereus strain 407 incubated with crude extracts, 
subfractions and compounds from aronia, compared to a non-treated control (Bacillus cereus 
407, first bar from left) for which average biofilm formation was set to 100%. 
 
Among the anthocyanins, compounds 2–4 induced biofilm mass production of the bacteria, 
however, when B. cereus 407 and E. coli JM109 were grown in the presence of compound 5, a 50% 
decrease in biofilm formation was observed. The cyanidin aglycone 1 possessed weak anti-biofilm 
activity against both bacteria. Thus, the ability to inhibit biofilm formation appears to be influenced by 
the sugar unit linked to the anthocyanidin. The largest variations in activity between the Gram-positive 
and Gram-negative bacterium were observed for the procyanidins. For B. cereus, monomeric 
epicatechin (6) increased biofilm mass, but dimeric (compounds 7 and 8), trimeric (compound 9) and 
polymeric (Seph d and Seph g) procyanidin fractions were effective in reducing biofilm production. 
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Since procyanidin B5 (dimer), C1 (trimer) and fraction Seph g (polymer) appear about equally active, 
there is no clear correlation between degree of polymerization and inhibition of biofilm formation.  
On the contrary, monomeric epicatechin decreased biofilm mass of E. coli, whereas dimeric, trimeric and 
polymeric (except for Seph d) procyanidins increased its mass. Interestingly, we observed a considerable 
difference in anti-biofilm activity between procyanidin B2 (7) and the isomeric procyanidin B5 (8), 
indicating that minor structural differences might influence the ability to inhibit biofilm formation. Also, 
it was found that neochlorogenic acid (11) was more active as a biofilm inhibitor against B. cereus than 
the isomeric chlorogenic acid (10). However, their effects against E. coli were negligible. 
Figure 3. Biofilm formation of E. coli JM109 incubated with crude extracts, subfractions 
and compounds from aronia, compared to a non-treated control (Escherichia coli JM109, 
first bar from left) for which average biofilm formation was set to 100%. 
 
The antibacterial activity of aronia substances against biofilm-forming E. coli JM109 (K12 strain) 
and B. cereus 407, and the uropathogenic E. coli strain CFT073 (which formed biofilm very poorly) 
was investigated by the disk diffusion method. Growth of the two E. coli strains was not affected by 
any aronia substance, and only 1.0 mg of the 50% EtOH extract showed some activity against  
B. cereus with a zone diameter of 10.2 ± 0.8 mm. However, it was much less efficient than the positive 
control gentamicin (10 μg) where a zone diameter of 20.5 ± 0.7 mm was observed. Hence, the 
inhibition of biofilm formation does not seem to be caused by toxicity towards the bacterial strains. 
Aronia samples might inhibit biofilm formation by interfering with quorum sensing, chemotaxis and/or 
motility genes that confer on cells a degree of motility in excess of that allowing adequate biofilm 
formation, as reported for E. coli K-12 exposed to ursolic acid by Ren et al. [1]. Investigation of the 
exact mechanism of this non-toxic inhibition, and also of potential effects of the compounds on already 
formed biofilms, would seem to be important subjects for further research. It has previously [2,23] 
been suggested that stress induced by the presence of the test substance might lead to increased 
production of EPS by the bacterial cell. This might be involved in the increase of biomass observed for 
some of the tested substances. At present, however, it is not clear why some of the test substances have 
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this effect, while others do not. Conceivably, there may exist a balance between anti-biofilm activity 
(such as disturbance of quorum sensing) and biofilm stimulating activity, and as shown in our study, 
this balance would seem to be dependent on minor differences in chemical structure. In our 
experiments, blanks without bacteria added to the growth medium served as negative controls for 
biofilm formation. We also included controls without aronia sample added, as negative controls for 
biofilm inhibition. This study was designed to investigate inhibition of biofilm formation, starting out 
from planktonic cultures. Thus, no antibiotics were added to the assay system, as the sensitivity of the 
planktonic bacteria to the antibiotics would not allow growth and formation of a biofilm structure. 
Future experiments may include testing the chemotolerance of cells within a biofilm, by adding 
antibiotics to a pre-formed biofilm. 
The prevalence of bacterial pathogens living in biofilms, where they are much more resistant to 
antibiotics and clearance by the immune system compared to planktonic cells, has promoted the  
search for new strategies to control biofilm infections [9]. Previous studies have included the  
influence of cranberry extracts on the formation of oral biofilms [24,25], on biofilm produced by  
Staphylococcus epidermidis on contact lenses [26], and by cranberry juice on biofilm produced by 
uropathogenic E. coli strains [27,28]. These studies confirm that cranberry juice can lead to a decrease 
in the ability of pathogenic bacteria to develop biofilm on inert surfaces such as urinary catheters and 
contact lenses. Cranberry contains A-type proanthocyanidins, which have been implicated as active 
constituents responsible for its bacterial anti-adhesive properties that prevent the attachment of E. coli 
onto uroepithelial cells, thereby preventing urinary tract infections [29]. However, it has previously 
been reported that cranberry juice is more effective than isolated cranberry proanthocyanidins alone  
in preventing biofilm formation [22,29]. In our study, the 50% EtOH extract was the most potent 
inhibitor of B. cereus biofilm formation. This might be due to the presence of unknown active 
compounds in this extract, or to synergistic effects. Against E. coli biofilm, epicatechin was the  
most effective substance tested, while effects of oligomeric and polymeric proanthocyanidins  
were negligible. Interestingly, cyanidin 3-xyloside showed activity against Gram-negative E. coli and 
Gram-positive B. cereus, whereas the other anthocyanins were inactive. Recently, a large number of 
flavonoids have been investigated for anti-biofilm activity towards Staphylococcus aureus [30].  
In that study, flavones, chalcones, flavonols, flavans, flavanones, isoflavonoids, neoflavonoids and 
dihydroflavonols were studied. Our work on catechins, anthocyanins and procyanidins would therefore 
seem to extend the range of active flavonoids. The results presented underscore the need for more 
research on the anti-biofilm effect of berries and their constituents. This work was intended to 
investigate whether aronia extracts and constituents can inhibit formation of biofilms. Other aspects 
such as study of other endpoints than biomass, dose-response relationships, and bacterial viability 
would be highly relevant subjects for future research. 
3. Experimental 
3.1. General 
Two Gram-negative Escherichia coli strains (E. coli K12 JM109, and uropathogenic E. coli 
CFT073 (ATCC 700928)) and one Gram-positive Bacillus cereus strain (B. cereus 407 wild-type [31]) 
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were used in the present study. For each organism, frozen glycerol (20%) stocks in lysogeny broth 
(LB) medium were prepared and maintained at í80 °C. A HTS 7000 Plus Bio Assay Reader  
(Perkin Elmer, Waltham, MA, USA) was used for UV-Vis measurements during the biofilm  
screening procedure. Gentamicin antimicrobial susceptibility test disks were obtained from Oxoid Ltd., 
(Basingstoke, UK). Epicatechin (6), chlorogenic acid (10) and neochlorogenic acid (11) were 
purchased from Sigma-Aldrich (St. Louis, MO, USA). 
3.2. Plant Material 
Aronia berries (Aronia melanocarpa (Michx.) Elliott var. Moscow (Rosaceae)) were harvested at 
Bioforsk Vest Særheim, Klepp, Norway (58°47'N, 5°41'E) in August 2010 and identified by one of the 
authors (R. Slimestad). The berries were kept at í20 °C until extraction. A voucher specimen 
(MB201201) is deposited in the Pharmacognosy section, School of Pharmacy, University of Oslo, 
Norway. Bark, as source of procyanidins, was sampled from the same plants. Branches with a diameter 
of 1–2 cm were chosen, and the bark was carefully removed. The plant material was cut in pieces and 
kept at í20 °C until extraction. 
3.3. Extraction, Fractionation and Isolation 
Aronia berries were extracted with DCM and 96% EtOH, 50% EtOH, and H2O followed  
by chromatography of the 50% EtOH extract to give subfractions Seph a–g, as previously  
described [17]. In parallel to this, cyanidin aglycone (1), four anthocyanins: cyanidin 3-galactoside (2), 
cyanidin 3-glucoside (3), cyanidin 3-arabinoside (4) and cyanidin 3-xyloside (5) and  
three procyanidins: procyanidin B2 (7), procyanidin B5 (8) and procyanidin C1 (9) were isolated from 
aronia berries (compounds 1–5) and bark (compounds 7–9). The detailed protocol for compound 
purification has been described previously [18]. Cyanidin was prepared by acidic hydrolysis of cyanidin 
3-galactoside. Cyanidin 3-galactoside (about 100 mg) was dissolved in MeOH (0.5% HCl, 5 mL) and 
mixed with 2 M HCl (5 mL). Hydrolysis occurred in a capped glass tube at 100 °C for 30 min. 
Cyanidin was isolated from the mixture by elution with 50% MeOH (0.1% HCl) over a bed of 
Sephadex LH-20 (3 × 40 cm Pyrex column). Purity was determined to be above 97% by HPLC [18]. 
3.4. Microtiter Plate Biofilm Formation Assay 
Biofilm screening was performed essentially as in Auger et al. [4], with some modifications. 
Microorganisms were streaked from frozen glycerol stocks (í80 °C) onto LB agar plates and incubated 
overnight (30 °C for B. cereus, 37 °C for E. coli). After growth on solid medium, an isolated colony 
was picked and inoculated in 5 mL LB medium for 18 h, at 30 °C for B. cereus and 37 °C for E. coli, 
under constant agitation at 225 rpm. Precultures were prepared by inoculating 50 μL of the 18 h 
culture in 5 mL LB medium (1:100), and incubated as before for 3 h. Further, 6 μL of the preculture 
was diluted in 1 mL fresh bactopeptone medium and 200 μL of test substance (dissolved in H2O  
or 10% MeOH in H2O) was added. 125 μL of each diluted culture was transferred to eight wells of a 
96-well PVC microtiter plate (Falcon 353911). In each plate, eight wells were used as blanks, 
containing bactopeptone medium only. For coloured samples, blanks contained bactopeptone medium 
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and the respective substances. After incubation for 48 h at 30 °C for B. cereus and 24 h at 37 °C for  
E. coli, which constituted the incubation times for which biofilm formation had been determined to be 
at its maximum for the given experimental set up, the biofilm density was measured as follows:  
the microtiter plate wells were washed once with phosphate-buffered saline (PBS) in order to remove 
non-adherent bacteria. Bacterial cells bound to the walls of the wells were stained with a 1% (w/v) 
crystal violet solution at room temperature for 20 min. The wells were then washed three times with 
PBS, followed by solubilization of the dye in an acetone/ethanol (1:4) mixture by slowly and 
continuously pipetting up and down three times to ensure extraction of the dye from cells. The mixture 
was immediately transferred to a transparent flat-bottomed microtiter plate and the absorbance at  
492 nm of the solubilized dye was subsequently determined. E. coli K12 JM109 and B. cereus 407 
were good biofilm-forming strains. Uropathogenic E. coli CFT073 was tested, but made a very poor 
biofilm under the same conditions. Screening studies of the various test samples on biofilm inhibition 
were carried out as three individual experiments, with eight technical replicates for each experiment, and 
the results are presented as averages ± SEM. Test sample concentrations of 1 mg/mL (125 μg per well) 
were applied. Samples dissolved in 10% MeOH in H2O had a total MeOH concentration of 1.7% 
during incubation. 
3.5. Antimicrobial Disk Susceptibility Test 
Antimicrobial activity was determined according to the guideline Performance Standards for 
Antimicrobial Disk Susceptibility Tests; Approved Standard—Ninth Edition (CLSI document M2-A9) [32]. 
A small amount of isolated colonies from 18 to 24 h old pure culture was suspended in sterile saline 
and the turbidity of this suspension was adjusted to a 0.5 McFarland standard. A dipped swab was then 
used to inoculate a Mueller-Hinton agar plate. Antimicrobial susceptibility blank disks (BBL, 6 mm in 
diameter), containing either 1.0 mg (50 μL, 20 mg/mL) and 125 μg (50 μL, 2.5 mg/mL) crude extract 
or 125 μg of compounds 1–11 and fractions Seph d and Seph g, were placed on the agar surface 
together with a positive control disk (gentamicin 10 μg) and a negative control disk containing 50 μL 
solvent (H2O or MeOH). Culture plates were incubated for 18 h at 37 °C, and zone diameters were 
recorded. All tests were performed in triplicate. 
4. Conclusions 
The presence of biofilms on medical devices and their role in infections is well known. The 
tolerance of catheter-associated biofilm-forming organisms toward antimicrobial treatments in the 
health care environment underscores the importance of alternative treatment strategies. In the present 
study, we have shown that exposure of biofilm-forming E. coli and B. cereus strains to several aronia 
constituents reduced biofilm production. Whether our results can be used in future development of 
biofilm inhibitors requires further investigation. 
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ABSTRACT 
Aronia berries are known for their high content of anthocyanins and proanthocyanidins 
which contribute to their high antioxidant potential. In the present study, four different 
cultivars of aronia berries, Aronia melanocarpa ‘Moskva’, ‘Hugin’, ‘Nero’ and Aronia 
prunifolia, have been studied with respect to phenolic composition, antioxidant and 
enzyme inhibitory activities. Cyanidin 3-galactoside was found to be the major 
anthocyanin in all cultivars, with the highest content in A. prunifolia (497 ± 20 mg /100 g 
FW). A. prunifolia was also found to have the highest content of polyphenols (2996 ± 172 
mg gallic acid equivalents/100 g FW) and proanthocyanidins (4.79 g procyanidin B2 
equivalents/100 g FW). As antioxidants and enzyme inhibitors, the differences between 
extracts from the tested berries were minor. The results indicate that berries from A. 
prunifolia constitute the richest source of polyphenols and might be the species of choice 
in order to attain berries with a high content of anthocyanins and proanthocyanidins. 
 
Keywords: Aronia melanocarpa; A. prunifolia; anthocyanins; proanthocyanidins; 
antioxidants; α-glucosidase 
 
 
 
 
 
Abbreviations: DPPH: 1,1-diphenyl-2-picrylhydrazyl; FW: fresh weight; 15-LO: 15-
lipoxygenase; PNP-G: para-nitrophenyl-α-D-glucopyranoside; XO: xanthine oxidase 
 
1. Introduction 
In recent years, a substantial interest in fruits and berries has developed due to their 
potential favorable health effects and their high content of polyphenols as flavonoids 
and anthocyanins (Miller & Shukitt-Hale, 2012; Tsuda, 2012; Wallace, 2011). The 
anthocyanins are a subgroup of the flavonoids, and they occur naturally in plants as 
glycosides. The anthocyanins contribute to the blue, red and purple color in many plant 
species. The aglycone is called anthocyanidin, and six principal types of anthocyanidins 
exist depending on the substituents on the B-ring: pelargonidin, cyanidin, delphinidin, 
peonidin, petunidin and malvidin. Anthocyanins have been suggested to have positive 
effects against obesity, diabetes and cardiovascular disease, as well as to have a positive 
effect on cognitive function (Miller & Shukitt-Hale, 2012; Tsuda, 2012). These effects 
have been attributed to the high antioxidant capacity of the anthocyanins, and the effects 
can more precisely be ascribed to molecular mechanisms, such as scavenging of free 
radicals, inhibition of radical forming and peroxidative enzymes, upregulation of 
antioxidant enzymes, regulation of signaling pathways and vasodilatory mechanisms 
(Mladenka, Zatloukalová, Filipský, & Hrdina, 2010; Sies, 2010).  
Proanthocyanidins or condensed tannins are oligomeric and polymeric compounds 
which consist of flavan-3-ols as monomeric units (Aron & Kennedy, 2008). The 
compounds are well known constituents of pine bark and grape seeds and are present in 
a wide variety of plant derived foods and beverages. They are the second most abundant 
phenolic compounds in nature after lignin (Gu et al., 2004). Proanthocyanidins have 
been widely investigated with respect to beneficial effects on cardiovascular diseases. 
Consumption of proanthocyanidin-rich foods such as red wine and cocoa (chocolate) 
seems to decrease blood pressure and insulin resistance and reverse endothelial 
dysfunction (Grassi et al., 2005; Heiss et al., 2007; Heiss et al., 2005; Taubert, Roesen, 
Lehmann, Jung, & Schömig, 2007).  
The genus Aronia (Rosaceae family) includes two species of shrubs, native to eastern 
North America and East Canada: Aronia melanocarpa (Michx.) Ell., known as black 
chokeberry and Aronia arbutifolia  (L.) Pers. (red chokeberry) (Kokotkiewicz, Jaremicz, 
& Luczkiewicz, 2010; Kulling & Rawel, 2008). Aronia prunifolia (purple chokeberry) is 
regarded as a hybrid between A. melanocarpa and A. arbutifolia (Kokotkiewicz et al., 
2010), it is however ambiguous if it is a separate species. Aronia prunifolia (Marshall) 
Rehder is indexed in The International Plant Names Index ("International Plant Names 
Index," 2012). Cultivars used for fruit production are from the species Aronia 
melanocarpa (e.g. berries are used for juice, jam and wine production). Commercially 
important cultivars in Europe and the United States include ‘Aron’, ‘Nero’, ‘Viking’, 
‘Hugin’ and ‘Rubina’. In Norway, the cultivar ‘Moskva’ is most common. The aronia 
berries contain high levels of flavonoids, mostly proanthocyanidins and anthocyanins, 
and in vitro and in vivo studies indicate that the berries may have potential health 
benefits, e.g. hepatoprotective effects, cardioprotective effects, and antidiabetes effect 
(reviewed by (Denev, Kratchanov, Ciz, Lojek, & Kratchanova, 2012; Kulling & Rawel, 
2008). In order to have a systemic biological effect and impact on health, sufficient 
amounts of bioactive compounds have to be absorbed through the gastrointestinal tract 
and reach the systemic circulation. The bioavailability of anthocyanins from aronia juice 
has been investigated in humans (Wiczkowski, Romaszko, & Piskula, 2010), and it was 
shown that both cyanidin glycosides and their methylated and/or glucuronidated 
derivatives were present in plasma. Generally, the bioavailability of anthocyanins is 
rather low. However, anthocyanin metabolites produced by the intestinal microflora are 
supposed to be absorbed and contribute to the beneficial health effects, as well (Manach, 
Williamson, Morand, Scalbert, & Rémésy, 2005; Williamson & Clifford, 2010). Nor is the 
bioavailability of proanthocyanidins fully understood. However, dimers and trimers of 
A- and B-type procyanidins have been detected in plasma of rats (Appeldoorn, Vincken, 
Gruppen, & Hollman, 2009; Shoji et al., 2006). Chokeberries are a rich source of B-type 
proanthocyanidins with contents above 5 g/100g dry matter (Oszmiański & Wojdylo, 
2005).  
 
Increased popularity of aronia products as functional food is expected in the future 
(Kulling & Rawel, 2008). New functional food products containing aronia berries or 
aronia juice are popular products due to their assumed health beneficial effects. In a 
recent study, we found that chokeberries were powerful antioxidants and enzyme 
inhibitors, and anthocyanins and proanthocyanidin-rich fractions from the berries could 
be responsible for the effects (Bräunlich et al., 2013). As far as we know, no scientific 
papers have described the differences in anthocyanin composition and in antioxidant 
capacity between the A. melanocarpa cultivars ‘Moskva’, ‘Hugin’, ‘Nero’ and A. prunifolia. 
In addition, aronia has been reported to ameliorate diabetes in humans (Simeonov et al., 
2002). While we have previously shown that some aronia constituents are inhibitors of 
D-glucosidase (Bräunlich et al., 2013), the difference between aronia cultivars has not 
been investigated previously.  Hence, the aim of this study was to investigate the 
chemical composition (quantification of anthocyanins and content of total phenolics and 
proanthocyanidins) as well as the biological activities (1,1-diphenyl-2-picrylhydrazyl 
(DPPH) radical scavenging and inhibition of 15-lipoxygenase (15-LO), xanthine oxidase 
(XO) and α-glucosidase) of these four berry sources.  
 
2. Materials and methods 
2.1.  Plant material 
Three A. melanocarpa cultivars (‘Moskva’, ‘Hugin’ and ‘Nero’) and an A. prunifolia 
cultivar were included in this study. The cultivar ‘Moskva’ was collected at Klepp, 
Norway (august 2010), ‘Hugin’ was collected in Tøyen Botanical garden, Oslo, Norway 
(August 2011), the cultivar ‘Nero’ was collected at Obstbau GbR, Coswig, Germany 
(September 2011) and A. prunifolia was collected in a private garden in Schönefeld, 
Germany (September 2011). The diameter of the berries was measured; results are 
shown as the average diameter of five berries of each cultivar.  The berries were kept at 
-20 °C until extraction. Voucher specimens are deposited at School of Pharmacy, 
University of Oslo, Norway (‘Moskva’ MB201201; ‘Hugin’ MB201202; ‘Nero’ MB201203; 
A. prunifolia MB201204). 
 
2.2.  Extraction of phenolics 
Frozen aronia berries, ‘Moskva’, ‘Hugin’, ‘Nero’ and A. prunifolia, (500 g of each) were 
extracted with boiling 80% ethanol with a reflux condenser for 2 h. The extraction was 
repeated twice. The extracts were filtered and combined, and then concentrated on a 
rotary evaporator followed by lyophilisation to give an 80% ethanol crude extract for 
each of the aronia cultivars.  
For anthocyanin analysis, 10 g berries of each cultivar were weighed and frozen at -20 
°C. The frozen berries were cut in small pieces, placed into a screw cap tube and freeze 
dried before extraction with 10 ml of methanol/0.5% trifluoroacetic acid (TFA) for 40 
minutes at 4 °C using a magnetic stirrer. The extraction was repeated four times, and the 
extracts were combined after filtration. Extraction was done in five parallels for each 
aronia cultivar. 
 
2.3.  HPLC analysis of anthocyanins 
Analysis was performed on a LaChrom Elite HPLC system (VWR-Hitachi) equipped with 
an L-2455 diode array detector. A Chromolith Performance RP18e 100 x 4.6 mm column 
(Merck, Darmstadt, Germany) was used for separation. Elution was performed using a 
gradient of mobile phase A (0.5% TFA in water) and mobile phase B (0.5% TFA in 
acetonitrile) with the following time schedule: 10% B, 0-1 min; 10-20% B, 1-3 min; 20-
85% B, 3-4 min; 85-10% B 4-5 min; and finally 10% B, 5-6 min for reconditioning of the 
column. The flow rate was 3.0 mL/min and injection volume was 10 μL. The anthocyanin 
absorbance was recorded at 520 nm, and separation took place at 25 °C. Three parallels 
of each extract were analysed. All samples were filtered (0.45 μm) prior to injection. 
Quantification of anthocyanins was based on a calibration curve of pure cyaniding 3-
galactoside (> 96%, determined by HPLC) isolated from aronia berries (Bräunlich et al., 
2013), assuming the same absorption coefficients for all anthocyanins (Jordheim, 
Enerstvedt, & Andersen, 2011). The results are expressed as mg cyaniding 3-galactoside 
equivalents per 100 g of fresh weight (FW).  
 
2.4.  Total phenolic content 
The total phenolic content was measured in the 80% ethanol berry extracts by use of the 
Folin-Ciocalteu method after adjustments (Singleton & Rossi, 1965; Wangensteen, 
Samuelsen, & Malterud, 2004). The results are expressed as mg gallic acid equivalents 
(GAE) per 100 g of FW or mg GAE/g extract.  
 
2.5.  Acid butanol assay for proanthocyanidins 
Proanthocyanidins were hydrolyzed to anthocyanidins by use of an n-BuOH-HCl-Fe(III) 
mixture, analyzed at 550 nm and content given as equivalents of procyanidin B2 
(Hagerman, 2011; Porter, Hrstich, & Chan, 1986). Aliquots (20-40 mg) of the 80% 
ethanol extracts were diluted to 10 mL in methanol (0.1% TFA).  From each aliquot two 
1 mL samples were assayed, the first one diluted 1:1 with acidic methanol whereas the 
second remained non-diluted. Hydrolysis was performed in capped tubes at 100 °C for 
50 min. Absorbances prior to hydrolysis were subtracted from absorbances of the 
hydrolyzed samples in order to adjust for the original anthocyanin content in the 
samples. 
 
2.6.  DPPH radical scavenging 
Scavenging activity towards the DPPH radical was carried out as previously described 
(Wangensteen et al., 2004). Briefly, to 2.95 mL of a methanolic solution of DPPH (A517 
1.0), 50 μL of the test compound (dissolved in DMSO) was added. The mixture was 
stirred and the decrease in UV absorbance at 517 nm was measured over a period of 5 
min. Percent radical scavenging was calculated as 100 x (Astart – Aend) / (Astart), where 
Astart is the absorbance before addition of test compound and Aend is the absorbance 
value after 5 min of reaction time. Values were corrected for absorbance of the test 
substances. Quercetin was used as a positive control. 
 
 
2.7.  Inhibition of 15-lipoxygenase (15-LO)  
Soybean lipoxygenase was used to measure inhibition of 15-LO. To a solution of linoleic 
acid (134 μM) in borate buffer (0.2 M, pH 9.00, 2.90 mL) was added 50 μL of test 
substance dissolved in DMSO or (for blanks) DMSO alone. A solution of 15-LO in 50 μL 
borate buffer (10.000 U/mL) was added, and the increase in absorbance at 234 nm from 
30 to 90 s after addition was measured. Percent enzyme inhibition was calculated as 100 
x [(∆A1 – ∆A2) / ∆A1], where ∆A1 and ∆A2 are values for increase in A234 for sample 
without test substance and with test substance, respectively (Wangensteen et al., 2004). 
Quercetin was used as a positive control.  
 
2.8.  Inhibition of xanthine oxidase (XO) 
The XO inhibitory activity with hypoxanthine as substrate was measured 
spectrophotometrically based on the procedure of Noro et al. (1983) with some 
modifications (Pham, Malterud, Paulsen, Diallo, & Wangensteen, 2011). The assay 
mixture consisting of 50 μL of test compound (dissolved in DMSO) or (for blanks) DMSO 
alone, 1.85 mL of 50 mM sodium-potassium phosphate buffer (pH = 7.5), and 100 μL of 
enzyme solution (1.8 U/mL in 50 mM sodium-potassium phosphate buffer, pH = 7.5) 
was prepared immediately before use. Substrate solution (1.0 mL, 20 μg/mL 
hypoxanthine in distilled water) was added. The mixture was stirred and the increase in 
absorbance at 290 nm was measured over a period of 5 min. Percent enzyme inhibition 
was calculated as 100 x [(∆A1 – ∆A2) / ∆A1], where ∆A1 and ∆A2 are values for increase in 
A290 for sample without test substance and with test substance, respectively. Quercetin 
was used as a positive control.  
 
 
2.9.  α-Glucosidase inhibitory activity  
The α-glucosidase inhibitory activity was determined by a slight modification of the 
procedure reported by Matsui et al. (1996). The enzyme solution was set at 800 mU/mL 
of α-glucosidase in a 50 mM phosphate buffer (pH = 7.0) containing 100 mM sodium 
chloride. For each assay, 20 μL of the test solution in DMSO and 80 μL of the enzyme 
solution were preincubated at 37 ˚C for 5 min. The reaction was started by adding 1.9 
mL of substrate solution (0.7 mM para-nitrophenyl-D-D-glucopyranoside (PNP-G) in the 
buffer) and the solution was then incubated at 37 ˚C for 15 min. After the reaction had 
been stopped by adding 2.0 mL of a 0.5 M Tris solution, the absorbance of PNP released 
from PNP-G at 400 nm was measured. Percent enzyme inhibition was calculated as 100 
x (AB - AS) / (AB), where AB and AS represent the absorbance of the blank and sample, 
respectively. Acarbose was used as a positive control. 
 
 
2.10.  Statistics 
Samples for total phenolic content, DPPH, 15-LO, XO and α-glucosidase assays were 
analysed in triplicate, for proanthocyanidin content in four parallells, and results are 
given as averages ± SD.  
 
3. Results and discussion 
3.1.  Anthocyanin composition 
The content of four anthocyanins, namely cyanidin 3-galactoside (1), cyanidin 3-
arabinoside (2), cyanidin 3-xyloside (3) and cyanidin 3-glucoside (4) (Fig. 1), in four 
cultivars of aronia berries was determined by HPLC in the acidified methanol extracts, 
and the identification of the individual anthocyanins was based on comparison with 
authentic standards previously isolated from aronia berries (Fig. 2) (Bräunlich et al., 
2013). The anthocyanins (1-4) have previously been identified as the major pigments in 
aronia berries (Kulling & Rawel, 2008); however the present results revealed large 
variations in content among the cultivars (Table 1). A. prunifolia was found to contain 
almost three times as high content of anthocyanins as A. melanocarpa, cv. ‘Moskva’ and 
‘Hugin’, whereas cv. ‘Nero’ contained 60% of the anthocyanin content of A. prunifolia. 
Cyanidin 3-galactoside was the major anthocyanin in all cultivars followed by cyanidin 
3-arabinoside. Cultivar ‘Nero’ and A. prunifolia were collected in Germany, whereas 
‘Moskva’ and ‘Hugin’ were collected in Norway, thus, unequal growing conditions may 
have had an impact on the results. However, the difference in anthocyanin composition 
that was found between cultivar ‘Nero’ and A. prunifolia indicate that there are large 
variations in anthocyanin content among different berry sources of aronia. A recent 
paper (Rugina et al., 2012) reports the total anthocyanin variation between A. prunifolia 
and two cultivars (‘Viking’ and ‘Aron’, not investigated by us) of A. melanocarpa. Our 
study describes for the first time the quantitative content of the individual anthocyanins. 
The total content is in accordance with the previous studies (Kulling & Rawel, 2008). 
Berries from A. prunifolia contain much higher levels of anthocyanins compared to the A. 
melanocarpa cultivars. These results indicate that berries from A. prunifolia might be a 
preferable species when a high content of anthocyanins is favored. The HPLC analysis 
was accomplished by using a reverse phase (RP) chromolith column. This is a monolithic 
column with the advantage of having a faster flow rate, thus giving a quicker separation 
compared to more commonly used RP-HPLC columns. In this study, the separation of 
four anthocyanins was accomplished in less than four minutes, a considerable advantage 
compared to anthocyanin analysis performed previously (Rugina et al., 2012) and in 
accordance with previous reports by use of this column (Arapitsas & Turner, 2008; 
Witzell & Lundström, 2007). 
 
3.2.  Extraction yield, content of total phenolics and proanthocyanidins 
The berries with diameters in the range from 8.4 ± 0.5 mm (A. prunifolia) to 12.9 ± 0.6 
mm (‘Moskva’) were extracted with 80% ethanol, and the extraction yields are 
presented in Table 2. The extraction of cultivar ‘Nero’ gave an extraction yield of 19.7%, 
more than twice that of ‘Hugin’. A. prunifolia berries contained roughly 50% more 
phenolics (expressed as gallic acid equivalents (GAE)) than the cultivar ‘Nero’ which had 
the highest phenolic content among the A. melanocarpa cultivars. The same trend was 
observed in the proanthocyanidin assay; A. prunifolia had the highest content of 
proanthocyanidins, followed by the cultivar ‘Nero’. This is probably due to the fact that a 
high proportion of the phenolics analyzed in the Folin-Ciocalteu assay are 
proanthocyanidins.  
 
3.3.  Antioxidant activities 
The antioxidant activities of the acidic methanol extracts and the 80% ethanol extracts 
were measured by the DPPH radical scavenging method, as well as by inhibition of the 
peroxidative enzyme 15-LO and inhibition of the prooxidative enzyme XO. The results 
are shown in Table 3. The 80% ethanol extract from ‘Hugin’ and A. prunifolia showed 
highest scavenging activities with IC50 values of 16.2 ± 0.4 μg/mL and 21.2 ± 0.7 μg/mL, 
respectively. The DPPH radical scavenging activities of the acidified methanol extracts 
were generally lower compared to the 80% ethanolic extracts. This could be due to the 
presence of proanthocyanidins in the 80% ethanol extract. Proanthocyanidins have high 
hydrogen donating capacity, a mechanism important for the reaction with DPPH 
(Yokozawa et al., 1998). Other low molecular weight compounds with phenolic 
structures might also be involved in the reaction with DPPH. Small differences between 
the aronia cultivars were observed in the 15-LO assay and the inhibitory activities were 
moderate. The 15-LO inhibitory activity was generally higher in the acidified methanol 
extracts than in the 80% ethanol extracts.  In the XO inhibition assay, small differences 
were observed between the cultivars, as well. In general, the 80% ethanol extracts were 
found to possess higher activities in this assay compared to the anthocyanin-rich 
extracts; this could be due to the content of proanthocyanidins and other polyphenols in 
the ethanol extracts.   
 
3.4.  Inhibition of α-glucosidase 
Inhibition of α-glucosidase delays carbohydrate digestion and the absorption of 
monosaccharides from the intestine (Adisakwattana, Yibchok-Anun, Charoenlertkul, & 
Wongsasiripat, 2011). The results from the α-glucosidase inhibition assay show that the 
acidified methanol extracts exhibited much higher inhibitory effects compared to the 
80% ethanol extracts (Table 4). The acidified extracts were composed mainly of 
anthocyanins (analyzed by HPLC), and we have shown previously (Bräunlich et al., 
2013) that these substances are potent inhibitors of α-glucosidase and may have 
beneficial effects in reducing blood glucose levels.  
 
 
4. Conclusion 
Our study shows that variations in chemical composition exist between different 
cultivars of aronia berries and between berries from A. melanocarpa and A. prunifolia. 
The A. prunifolia species has relatively small berries, but they give a large extraction 
yield with alcohol and show the highest content of anthocyanins among the tested 
berries. As antioxidants, the differences between extracts from the tested cultivars were 
less prominent. The anthocyanin fractions were shown to be potent D-glucosidase 
inhibitors. The presented results show that among the aronia berries tested, A. prunifolia 
constitutes the richest source of polyphenols and might be the best species when a high 
content of anthocyanins and proanthocyanidins is preferred.  
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Fig. 1 - Chemical structures of major anthocyanins in aronia berries.  
 
Fig. 2 - RP-HPLC chromatogram of acidified methanolic extracts of berries from aronia:  a) 
‘Moskva’; b) ‘Hugin’; c) ‘Nero’; d) A. prunifolia. The anthocyanins shown are 1: Cyanidin 3-
galactoside, 2: Cyanidin 3-glucoside, 3: Cyanidin 3-arabinoside and 4: Cyanidin 3-xyloside. Y-axis 
is shown from -100 to 2200 mAU, x-axis from 0 to 5 minutes. 
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Table 1 
Anthocyanin content from four cultivars of aronia berries 1 
 1. Cyanidin 3-
galactoside 
2. Cyanidin 3-
glucoside 
3. Cyanidin 3-
arabinoside 
4. Cyanidin 3-
xyloside 
Total 
’Moskva’ 168.4 ± 11.9 tr2 83.0 ± 6.6 2.7 ± 0.8 251.5 
’Hugin’ 196.9 ± 15.5   tr 51.6 ± 5.9 tr 248.5 
‘Nero’ 281.7 ± 25.3 4.7 ± 0.4 149.2 ± 14.7 11.7 ± 1.0 447.3 
A. prunifolia 496.8 ± 19.9 tr 236.2 ± 13.2 3.8 ± 0.7 737.3 
1 presented as mg cyanidin 3-galactoside equivalents/100 g FW; 2 trace 
 
Table 2 
Diameter, extraction yield, total phenolic content and total proanthocyanidins of four cultivars of 
aronia berries 
 
Diameter  Yield of  80% 
EtOH extract 
Total phenolic content1 
 
Total 
proanthocyanidins3 
 
mm % of FW mg GAE/g 
extract2 
mg GAE/100 
g FW 
g PCB2/100 g FW 
’Moskva’ 12.9 ± 0.6 10.7 % 101.1 ± 5.6 1079 ± 60  2.461 
’Hugin’ 9.6 ± 0.8 9.4 % 147.6 ± 5.6 1389 ± 53 2.820 
’Nero’ 12.6 ± 0.5 19.7 % 97.5 ± 15.0 1921 ± 296 3.743 
A. prunifolia 8.4 ± 0.5 17.1 % 175.3 ± 10.1 2996 ± 172 4.788 
1 presented as mg gallic acid equivalents (GAE); 2 80% EtOH extract; 3 presented as g procyanidin B-2 
equivalents  
 
Table 3  
Antioxidant activity of four cultivars of aronia berries tested by DPPH radical scavenging, 
inhibition of 15-lipoxygenase (15-LO) and inhibition of xanthine oxidase (XO).  
 DPPH 15-LO XO 
 
IC50 (μg/mL) % inh 83.3 
μg/mL 
% inh 83.3 
μg/mL 
80% ethanol extract ’Moskva’ 35.7 ± 1.5 4.0 ± 2.7 25.5 ± 3.0 
80% ethanol extract ’Hugin’ 16.2 ± 0.4 10.9 ± 2.9 34.5 ± 2.0 
80% ethanol extract ’Nero’ 35.5 ± 1.4 8.9 ± 3.1 23.7 ± 4.1 
80% ethanol extract A. prunifolia 21.2 ± 0.7 5.7 ± 3.4 26.3 ± 2.7 
Acidified methanol extract ‘Moskva’ 61.4 ± 1.6 8.5 ± 4.7 2.7 ± 1.6 
Acidified methanol extract ‘Hugin’ 39.7 ± 1.4 12.8 ± 5.7 14.7 ± 1.8 
Acidified methanol extract ’Nero’ 54.3 ± 1.6 17.4 ± 5.2 13.0 ± 3.8 
Acidified methanol extract A. 
prunifolia 
33.2 ± 1.3 14.7 ± 5.0 18.0 ± 5.5 
Quercetin (positive control) 3.3 ± 0.6 26.0 ± 2.0 1 0.6 ± 0.11 
1 presented as IC50 (concentration to give 50% inhibition) 
 
Table 4  
Inhibition of D-glucosidase of extracts from four cultivars of aronia berries 
 IC50 (μg/mL) 
80% ethanol extract ’Moskva’ 0.70 ± 0.08 
80% ethanol extract ’Hugin’ 0.83 ± 0.10 
80% ethanol extract ’Nero’ 0.88 ± 0.08 
80% ethanol extract A. prunifolia 0.88 ± 0.08 
Acidified methanol extract ’Moskva’ 0.049 ± 0.002 
Acidified methanol extract ’Hugin’ 0.030 ± 0.003 
Acidified methanol extract ’Nero’ 0.044 ± 0.006 
Acidified methanol extract A. prunifolia 0.030 ± 0.005 
Acarbose (positive control) 130 ± 20 
 
 
